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ABSTRACT OF THESIS (Regulation 7.9)
This thesis initially reviews the ancient and modern literature on the
oesophagus, and its investigation. The current literature on reflux
oesophagitis is evaluated, and modern concepts of aetiology are discussed.
The five year endoscopic experience of reflux disease for the Portsmouth
gastroenterologists is quantified, and it is shown that this is a widespread
condition affecting all adult age groups, with a predilection for the elderly.
The current gold standard test for acid reflux - 24 hour pH testing -
is evaluated. A new method of interpreting pH test results (the area under
the curve) is compared with the more usual cumulative acid index. It is
shown that the new method is no more accurate than the old, when trying to
separate normal from abnormal pH test results, suggesting that factors other
than acid may also be involved in the aetiology of reflux disease.
Measurements are performed on samples of human oesophageal refluxate,
looking at three other factors which may be implicated in reflux
oesophagitis, namely bile salts, trypsin and pepsin. These factors are
compared with the pH of the refluxate. It is shown that significant
quantities of all three substances are present in the samples, across the pH
range, rather than in the narrow pH bands expected. Bile salts are selected
for further study.
The development of a system for measuring bile reflux using an external
gamma detector and 75SeHCAT labelled bile is outlined, and tested. It is
shown that this system is insensitive as a measure of bile reflux, but is
capable of monitoring the enterohepatic circulation.
The developmental program for a new, internal gamma probe and portable
monitoring system for use within the gastrointestinal tract is outlined. In
vitro studies show this to be highly sensitive to 75SeHCAT, and 33Tcn'HIDA,
despite its small size.
The internal gamma probe is validated as a measure of bile reflux in
human volunteers using a gamma camera for comparison of results. In all
cases studied, correlation between counts from the internal probe and gamma
camera are shown to be positive, and are strong]y suggestive that bile
reflux is being measured. This system can therefore be regarded as the first
effective portable bile reflux detector, with significant potential for the
further study of reflux related disease.
PGS/ABST/83 Use this side
Of the Heart-burn
"What is commonly called the heart-burn, is not a
disease of that organ, but an uneasy sensation of heat,
or acrimony, about the pit of the stomach, which is
sometimes attended with anxiety, nausea, and
vomiting.
It may proceed from debility of the stomach,





The discovery of acid and bile
The aetiology of reflux oesophagitis is intimately related to both hydrochloric
acid and bile salts. Both of these substances have long been known to man, although
their relevance to disease has only become clear in the 20th century. A very full
account of the history of bile salts is given in K W Heaton's paper "Bitter Humour",
and the following outlines this.
The ancient Greeks evolved a medical doctrine based on four humours - blood,
phlegm, black bile and yellow bile. Yellow bile had the attributes of fire, and was
hot, dry and tasted bitter, while black bile was cold and melancholic (the greek word
"melon" means black, and "chole" means bile). Gastric digestion of food was thought
to be brought about by heat, supported by black bile, which was regarded mainly as
an excretion product until the seventeenth century AD. In 1683, the Dutch anatomist
Diemerbroeck suggested for the first time that bile may have digestive qualities
"dissolving and separating the thinner parts of the chyle from the thicker ones so
that they may easily be taken up by the lacteal vessels".
In the eighteenth century the physicians John Arbuthnot and Thomas Coe both
noted that ox bile was sometimes used as an alternative to soap for washing clothes.
There followed in the nineteenth century some important experiments by a number
of individual German scientists, who by creating biliary-cutaneous fisiuiae in
animals, showed that large excesses of fat were thereby excreted in the stools. These
demonstrations of steatorrhoea proved the digestive qualities of bile.
The individual glycocholic and taurocholic acids were isolated by chemists in
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the mid nineteenth century, and during the same period it was noted that there was a
continuous recirculation of these bile salts between the bowel and the liver.
Hydrochloric acid is first mentioned in the literature of the late fifteenth
century when it was distilled from alum and salt, and used for the softening of bones
(unknown Italian author - cited by Reti 1965). One hundred years later Paracelsus
(cited by Pagel 1956) described acid in the stomachs of animals, but thought that this
was ingested rather than being excreted by the stomach.
In the early seventeenth century the Belgian doctor and chemist Van Helmont
made the important observation that gastric secretions were themselves acidic, and
noted the similarity with "spirit of sea salt" or hydrochloric acid, which he could
make by distilling sea salt and potters clay. He compared the action of gastric juice
with the action of "liquor of sulphur" or sulphuric acid on leather (cited by Reti
1965, Pagel 1956), although he also regarded the spleen as the source of the
digestive agent.
It was the development of acid/base indicators in the late seventeenth century
which led to the final proof that gastric juice contained acid. Viridet (cited by Baron
1979) poured heliotrope extract down the throat of a pig, and demonstrated that the
oesophageal mucosa was stained blue by it, indicating alkaline, whereas the stomach
lining was stained a deep red, indicating acid. He also described acid regurgitation
into the oesophagus and mouth.
The Italian physiologist Spallanzani (cited by Prescott 1929) isolated "marine
acid" or hydrochloric acid from the stomachs of crows by feeding them retrievable
sponges and analysing the extracts. He also showed that these juices would only
digest food adequately when kept at body temperature. Spallanzani was involved in
an animated correspondence with the Scottish anatomist and surgeon John Hunter,
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who believed that digestion was mainly independent of body heat, and that gastric
acidity was due to decomposition of sugar in food. Misconceptions such as this
continued on into the early nineteenth century when many still believed that gastric
juice was saliva, and any acid present was secondary to the digestive process.
It remained for William Prout, the father of British biochemistry, to resolve the
problem once and for all. In 1823, he quantified "muriatic acid" (HC1) from the
stomachs of a large variety of mammals and also from humans using an early
titration technique. He also postulated that chloride was secreted from the blood to
the gastric lumen by the power of electricity, and that as hydrochloric acid was
secreted, so the blood became alkaline.
In 1825, William Beaumont (cited by Rosen 1943) also isolated hydrochloric
acid from human stomach using the gastric fistula of his well known patient Alexis
St Martin. A few years later in 1834, it was noted by Eberle in Germany that
hydrochloric acid and a neutral gastric mucosal extract were inactive alone, and
would only cause digestion when mixed together. The following year Schwann
isolated the mucosal extract and called it pepsin.
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A History of Oesophageal Investigations
2500BC to 1800AD
The first medical records relating to the oesophagus date back to approximately
2500BC. The "Edwin Smith Surgical Papyrus" of ancient Egyptian times describes the
fistula created by a "wound of the throat piercing the gullet", and contains the first





Thou shouldst draw together that wound with stitching.
THE EDWIN SMITH SURGICAL PAPYRUS
The writer goes on to describe binding the wound with fresh meat, honey and
lint, with further dressings leading to patient recovery.
Until the 15th century AD there are no further medical references to the
oesophagus, but in 1490, Avenzoar described cannulation of the upper oesophagus in
patients with dysphagia. The next references were again to surgery and occurred in
1672, when Wiseman described suturing a tear in the oesophagus of a child who had
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fallen onto a wooden dagger. By the early 18th century, cervical oesophagotomy was
occasionally being performed for treatment of stricture formation, and the removal
of foreign bodies. Thomas Willis, the physician who described the sweet taste of
diabetic urine, also described the first known case of achalasia in 1679, and
performed dilatation of the cardia using a whalebone rod.
Bouginage for oesophageal stricture was first described by Vareliaud in 1801,
and Lanelongue described an instrument with a cutting blade for the same purpose in
1867, although, not surprisingly, blind division of oesophageal strictures was
associated with a high mortality rate. Balloon dilatation was first performed by
Russell in 1887, on a case of achalasia, using a rubber balloon covered in silk on the
end of a bougie. The technique was successful in the five cases on which it was
attempted.
The procedures outlined above were all hampered by the fact that the
oesophagus itself could not be visualised, although there were many early attempts at
this. The next section describes the evolution of endoscopic techniques in relation to
the upper GI tract.
The development of endoscopy.
Philipp Bozzini is credited with inventing the first simple endoscopic instrument
for viewing the pharynx, although it was primarily intended for examining the
vagina, the rectum, and the female urethra and bladder. It was called the
"Lichtleiter" and it used a beeswax candle as its light source. This unfortunately
provided insufficient illumination for it to be of any true diagnostic value.
Several further designs of "candle powered" endoscope were used in the first
half of the nineteenth century, mainly for examining the bladder and rectum. The
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Desormeaux lamp of 1865 was a considerable improvement on the candle, and
utilised a burningmixture of alcohol and turpentine (gasogen) as its light source.
John Bevan described upper oesophagoscopy in 1868 in the Lancet, and although his
main light source was the candle, he also described a "limelight" based on a burning
mixture of hydrogen and oxygen, and a Magnesium lamp based on a burning
Magnesium wire, neither of which could have been very pleasant for the patient.
In the same year of 1868, the first gastroscopy was performed by Adolph
Kussmaul in Germany (cited by Schindler 1937). He succeeded in passing a rigid
open tube, with obdurator, down the length of the oesophagus of a sword swallower,
into the stomach. Even using the Desormeaux lamp, little could be visualised, but his
demonstration proved that rigid instruments could traverse the natural curves of the
thorax, and paved the way for the development of further rigid oesophagoscopes
(MacKenzie) and gastroscopes.
The most significant advances of the nineteenth century were made by the
cystoscopists, with the advent of electrical illumination, which allowed a light source
to be placed at the distal tip of the examining instrument. Nitze and his optical
assistant, Leiter are credited with making the first cystoscope with an electric light
source in 1879, and Nitze also constructed a gastroscope, although this proved
unsuccessful, due to the complicated cooling systems required by the hot platinum
loop electrode used to provide light.
In his celebrated paper of 1881 Johann von Mikulicz described the first
adequate endoscopic examinations of the stomach, using morphine narcosis, and
diagnosed carcinoma and gastric ulcer using this technique. His work was not
followed up however, due to technical difficulties, and it is thought that accidents
may have occurred (Schindler 1950).
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In 1896, Rosenheim was the first
to use an Edison light bulb for
illumination of the oesophagus and
stomach, but his and several other
rigid endoscopes of the 1890s were
all very impractical, and were not
widely used (cited by Walk 1966). In
1902, Einhorn perfected a rigid
oesophagoscope, with an electric light
source at its distal tip (Fig 1), which
he had some success with. In his book
"Diseases of the Stomach", he
described examination of his patients
in the "sword swallowing" position
(Fig 2), without anaesthesia, but went
on to say that gastroscopy using the
same technique was both difficult and
dangerous.
It was in the early 1900s, that
the technique of endoscopy came into
its own, with the development of
better optics. Chevalier Jackson was
one of the earliest surgeons to
regularly examine the stomach. He
emphasised the safety aspects, Figure 1
A. Hollow metal
tube.










and stated that although the examination of the oesophagus could be performed with
only local cocaine anaesthesia, viewing the stomach required general anaesthesia with
chloroform or ether. He described the prone, neck extended position for the patient,
and by simultaneous palpation of the abdomen, could examine one half to three-
quarters of the gastric mucosa. In later papers, he described examination of the
pylorus (pyloroscopy), and also use of gastric biopsy for the diagnosis of benign and
malignant ulcer.
The real architect of modern endoscopy was Rudolf Schindler, who first
experimented with rigid endoscopes, in the 1920's, and then invented the first semi-
flexible instrument in 1932. This was based on a system of more than fifty lenses to
Fig 2. Rigid oesophagoscopy 1902
A tribute to the endurance of the Edwardian Lady
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transmit the image through an arc of up to 34° (Davies 1972). The addition of
controls to flex the distal tip of the instrument was a further major advance (Taylor
1941) and not only enhanced examination of the distal stomach, but also added to the
safety of the technique.
The invention of a coherent glass f ibre bundle capable of transmitting an optical
image along a flexible path was made by the physicist, Harold Hopkins at Imperial
College, London in 1953. (Hirschowitz 1958, Burnett 1962, Salmon 1972). The
technology was adapted, and developed into a prototype fibreoptic gastroscope by a
South African, Basil Hirschowitz in the USA, but it was several years before he
could persuade an American Company (American Cystoscope Makers Inc.) to produce
a commercially viable instrument. These became available in 1960, and were first
used in Alabama, USA. The first flexible instruments were wide, (I inch diameter)
and although they made examination of the whole of the stomach possible, they
could not enter the duodenum (Burnett).
The potential for these early flexible instruments was quickly recognised by the
Japanese, and within a few years, Olympus were producing the high quality
fibreoptic endoscopes, which have so dramatically changed our practice of
gastroenterology today. A further refinement of the instrument in the early 1970's
was the side viewer, which has led to our present techniques of endoscopic
retrograde cholangio-pancreatography (ERCP), with its potential for non-operative
removal of stones, and stenting of biliary strictures (Cotton 1972).
X-Rav techniques.
The rigid endoscope was then, the first truly diagnostic tool to be used, and
predated the first use of X-Rays by some thirty years. Wilhelm Roentgen discovered
the phenomenon of the X-Ray in 1895, and two years later in 1897 Cannon carried
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out the first X-Ray contrast series, looking at the passage of bismuth subnitrate
down the gullet of a goose. In the same year, Bliss reported using X-Rays to
examine a foreign body lodged in a patient's upper oesophagus.
By 1908 the techniques of barium meal, follow through, and enema were being
used regularly in man (Carman 1913, Harrington 1928), and sporadic reports of
diaphragmatic hernia began to appear in the literature soon afterwards (Abbott 1924,
Friedenwald 1925, Kirklin 1947).
In the first half of this century, radiology was felt to complement endoscopy in
the study of the oesophagus (Auguste 1951), and was certainly better at diagnosing
functional abnormalities such as spasm and disordered peristalsis. Barium studies also
proved effective in the diagnosis of gross lesions of the oesophagus such as
carcinoma, ulceration and stricture formation, but have always been less useful for
diagnosing oesophagitis. The barium cine-oesophagogram provided an objective
measurement of gastro-oesophageal reflux in the 1950's and '60s, and the
combination of acid and barium mixtures was used with some effect for the
evaluation of oesophagitis, by looking at motility patterns (Donner 1966). Screening
Barium swallows have provided much useful information about the incidence of
diaphragmatic and hiatus hernia. (Giffin 1912, Stein 1960).
Although to a great extent, X-Ray techniques have now been superseded by
endoscopy and manooetry, they are still useful, and as recently as 1976, barium
sulphate tablets were used to demonstrate the delayed passage of potentially corrosive
medications through the oesophagus (Evans 1976).
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Surgery of the oesophagus.
The development of endoscopic and X-Ray techniques made accurate
examination of the oesophagus possible. This, together with important developments
in anaesthesia (Long 1849), and antisepsis (Lister 1867) enabled surgeons to perform
more major surgery than had previously been attempted.
The first effective oesophageal surgery, other than simple esophagotomy, was
for achalasia, and was described by Heller in 1913. He performed an anterior and
posterior longitudinal myotomy over the cardia with excellent effect.
Sporadic cases of oesophageal resection for carcinoma were being reported as
early as 1877 (Czerny), but safe and effective techniques were not developed until
after the Second World War, when Brewer, and Ivor Lewis in 1946 pioneered the
high gastric replacement, which involved mobilising the stomach up into the thorax,
for anastomosis to the cervical oesophagus.
Surgery for hiatus hernia was originally much the same as repair of any hernia
- a simple reduction and repair of the defect. Harrington (1928, 1930) described
phrenic nerve division to relax the diaphragm either on its own or with a simple
overlap repair of the crus as being effective, but the more major procedure had a
17% mortality rate, due to respiratory problems. In 1946 Allison described a similar
operation, and by 1951 he had performed 33 such procedures, with only one death.
Allison also advocated distal oesophagectomy with oesophagojejunostomy for patients
with refractive oesophageal ulceration, and achieved good results from operations on
15 patients.
These techniques were superseded, when in 1956 Nissen described a more
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effective anti-reflux procedure, which involved mobilising the oesophagus into the
abdomen for 6cms and then wrapping the fundus of the stomach around it (Fig 3). He
named the procedure fundoplication, and with modifications, this is still one of the
most commonly performed anti-reflux operations. Modifications of Nissen's
procedure were introduced by Hill, and Belsey. They have been shown not only to
increase lower oesophageal sphincter pressure but also to increase the amplitude of
peristaltic contractions (Fisher 1978, Gill 1986).
Fig 3 - The Nissen Fundoplication.
The recognition in recent years that biliary and pancreatic secretions can cause
oesophagitis, especially after gastrectomy, has led to biliary diversion procedures
being performed with good results. In particular the long-limb Roux-en-Y, with a
45cm between the oesophageal anastomosis and the afferent segment, has proved





Prior to the 1950's, estimations of gastric acidity were usually performed using
the phenolphthalein end point titration method, but in situ electrodes were in
preliminary use mainly for gastric/duodenal secretion studies in 1939 (Eyerley,
Flexner). In 1952 Rovelstad described measuring oesophageal pH with a shielded
glass electrode, but these were only short recordings, with the emphasis of his tests
being on the stomach and duodenum.
In 1958 two tests for oesophageal pathology were described, both of which have
had a profound effect on our present understanding of reflux oesophagitis, and
which in modified form, are still in frequent use today. The first of these was the
"Acid Perfusion Test for Oesophagitis" described by Bernstein. He perfused the
oesophagus of 55 patients with 0. IN HC1, using Normal Saline as a control, and
showed conclusively that in those patients with oesophagitis, he could elicit their
symptoms with the acid perfusate. He showed that the test would confirm the
oesophageal origin of symptoms in patients without oesophagitis, and concluded that
this would be particularly useful in differentiating between pain of cardiac origin,
and that of oesophageal origin.
Eyerly's miniature glass pH electrode was first used in the oesophagus by Tuttle
and Grossman, in 1958. They described placing the pH electrode via the nose into
the mid oesophagus to directly measure acid regurgitation. They did not, in their
initial experiments, record the patients symptoms during the test, but they were the
first to directly measure gastro-oesophageal reflux of acid. The pH test has
undergone an almost continuous process of refinement since then, and is now
regarded as the Gold Standard test for reflux (Silverstein 1980, Evans 1987,
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Schindlbeck 1987, Johnsson 1987). Prolonged pH studies were started during the
1960's (Spencer 1969, Miller 1964, 1967), and in 1974, Johnson and DeMeester
described a mobile system consisting of a glass electrode and cable attached to a strip
chart recorder on a movable trolley which facilitated ambulatory recordings of up to
72 hours. The first truly portable systems appeared in 1980 (Falor), when pH
sensitive radiotelemetry capsules were used, with the results being stored on a tape
recorder worn on a waistbelt. It was as recently as 1984, that Vitale first described
our present system of recording on portable microprocessors, with direct computer
analysis of results. Several of these systems are now available (Vertec, Synectics,
Gaeltec, Oxford)
Motility studies.
Oesophageal transit time was traditionally measured by listening with a
stethoscope over the cardia for deglutition sounds as the patient swallowed liquid.
This technique was really only useful for the diagnosis of strictures and achalasia.
(Kronecker & Meltzer 1883, Winklestein 1935).
Manometry was first performed in Germany in 1883 by Kronecker and Meltzer,
using rubber air balloons in the pharynx and oesophagus to study normal swallowing.
They described peristalsis, as well as refuting the idea of anti-peristaltic waves in
the oesophagus, and also demonstrated oesophageal dysmotility after swallowing a
carbonic acid mixture. Sixty six years elapsed however, before Kramer and
Ingelfinger used a "balloon kymograph" to examine motility in the abnormal
oesophagus.
In 1943, Wetterer invented a miniature electromagnetic pressure transducer
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small enough to be placed in the trachea, or internal jugular vein, and in 1956 this
technique was modified by Fyke et al for measuring pressures in the GI tract. They
discovered "a zone or band of high pressure interposed between the stomach below,
and the oesophagus above ... detectable for distances of 2 to 3cms", and concluded
that this was a functioning sphincteric mechanism - a fact not previously recorded.
These findings were confirmed the following year by Atkinson et al using an air
perfused open ended tube system for pressure measurement.
Radioisotope studies
The use of radionuclides to examine the oesophagus was first described in 1972
by Kazem. He studied the oesophageal transit time of a Tc"m labelled pertechnetate
drink, using gamma camera imaging, producing a test for transit time which was
both accurate and involved a very low radiation dose. He called his test the
"radioesophagram" or REG. Tolin quantified this test in 1979, by collecting the
scintiscanner data on a digital computer. This was then analysed using an "area of
interest" over the oesophagus, to calculate the exact rate of transit of the labelled
fluid.
Fisher et al first described the use of a gamma camera to detect and quantitate
gastro-oesophageal reflux of a Tc99m sulphur colloid, but it could not be described
as wholly physiological as an artificial pressure gradient was used to induce reflux
during the limited time of the test. Although this test is still in use for the
measurement of reflux (Krog 1982, Kaul 1985, 1986), it is not thought to be so
useful in the study of oesophageal motility disorders (Mughal 1986).
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The development of a modern perspective on reflux oesophagitis
Diaphragmatic hernia
Although the relationship between hiatus hernia and oesophageal reflux remains
a controversial one, the history of diaphragmatic herniae in general, forms an
interesting and important background to our present day view of the subject.
The first description of diaphragmatic hernia is attributed to Ambroise Pare in
1610. He described two cases of hernia, both of whichwere traumatic in origin. The
first involved a Captaine Francois d'Alon of Xaintonge, who was shot in the chest by
an arquebus. He survived the injury only to die of intestinal obstruction eight months
later. At post-mortem a large part of his colon was found "distended with gas" in the
thorax, having herniated through a hole in the diaphragm no larger than the base of
the little finger. In the second case, stomach and small intestine were found to have
herniated into the chest of a soldier at post-mortem, thirteen days after a wound to
the membranous portion of the diaphragm.
The congenital type of diaphragmatic hernia was first described in 1698 by
Riverius (cited by Unger & Speiser), and until the 20th century it was regarded as a
rare condition, with only 10 live cases being reported prior to 1908 (Harrington),
and 15 prior to 1912 (Giffin).
Andrew in the Lancet in 1903 is thought to have described the first case of
herniation of the cardia through the oesophageal hiatus. Over the next 20 years or
so, with the increasing use of X-Ray techniques, it was gradually realised that hiatus
hernia was quite a common phenomenon (Abbott 1924, Friedenwald 1925)
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Early thoughts on aetiology
Ulcers and inflammation of the oesophagus were described by Quinke as early
as 1879, but the aetiology of heartburn and oesophagitis remained obscure until 1884
when Reichmann performed an experiment on three patients with heartburn, and
three normal subjects. He persuaded them to swallow small gelatin coated sponges
attached to silk thread, placing them in the mid oesophagus. On withdrawing them,
he found that those sponges from patients with heartburn contained fluid which gave
an acid reaction, while those from the asymptomatic subjects were alkaline.
Reichmann believed that the cardia was a factor in the aetiology of heartburn, and
that its degree of contraction was related to the extent of a patient's symptoms.
The vomiting of bile stained fluid associated with heartburn after gastrectomy
was described by Hartman in 1921, but no relationship between the two was
suggested. Jones and Richardson in 1926 described heartburn as being due to
oesophageal spasm as a result of exposure to acid, alkaline, or gastric contents, a
finding which was corroborated by Payne and Poulton. Two years later, Chevalier
Jackson reviewed 88 patients with "peptic oesophageal ulcers", using the rigid
oesophagoscope. He came to the interesting, but somewhat erroneous conclusion that
infection was the chief aetiological factor in the development of the disease, with the
infective focus commonly being the tonsil. He regarded retrograde flow of gastric
contents as being a perpetuating factor only, but a certain cause of pain. Jackson also
stated quite categorically that there was no evidence for a sphincter mechanism at
the anatomical cardia, and that the diaphragmatic pinchcock was normal in all his
patients with oesophageal ulcer. Kofler, in 1928, reported relief of heartburn by




Post-mortem studies by Mallory and Weiss in 1932 described acute lacerations
of the oesophagus following prolonged vomiting, and in the same paper they
described the formation of chronic ulcers at the cardia. They postulated that these
were caused by "regurgitation of gastric juice and the corrosive effect of alcohol".
The in vivo condition of reflux oesophagitis was first described as recently as
1935, by Winkelstein. He listed the causes of oesophagitis as:
1. Irritative (mechanical, thermal and chemical).
2. Specific (Syphilis, TB, actinomycosis).
3. Secondary, as a complication of cardiospasm, diverticula or neoplasm.
To these he added a fourth category which he presented as a separate clinical entity
- a "peptic" oesophagitis which he suggested was due to "the irritant action on the
mucosa of free hydrochloric acid and pepsin". He concluded that "heartburn may be
due to peptic oesophagitis", and in doing so made a significant contribution to our
modern understanding of the condition.
Over the next twenty years there was a gradual realisation that peptic
oesophagitis was not just a terminal condition seen in debilitated patients, but was in
fact a common disease (Allison 1946, 1951), although its relationship to heartburn
was still seldom considered (Beaconsfield 1953).
The presence of hiatus hernia, and incompetence of the gastro-oesophageal
junction were both recognised as predisposing to reflux (Allison 1951, Aylwin 1953,
Flood 1953, Stewart 1955) but it was also shown that acid reflux could occur in the
absence of a demonstrable hernia (Flood 1953, 1955). The spasm theory of
oesophageal pain was still widely accepted (Moersch 1943) until questioned by
Bernstein who in 1958 showed a direct relationship between mucosal acid exposure
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and heartburn. The prolonged pH and manometry recordings that can now be
performed have still failed to uncover the exact cause of oesophageal pain, although
they can now help to differentiate oesophageal pain from that of cardiac origin
(Janssens 1986).
Even in the 1950's, the origin of oesophagitis was still often thought to derive
from infections such as cholecystitis, tonsillitis or pneumonia, with bacterial
dissemination via veins and lymphatics (Auguste 1951, Allison 1946). Auguste also
mentions an "allergic" type of oesophagitis, although he does not expand on this.
Moffat in 1965 listed vitamin deficiencies, vascular aberrations and inherent
susceptibility to the trauma of ingested food among the possible causes of thg disease.
The mechanism for production of the lesion remained far from clear however. The
"acid/pepsin theory" could not explain the observations of Helsingen (1958), Palmer
(1960), Windsor (1964) or Morrow (1976) that oesophagitis occurred in patients who
had undergone gastrectomy, or in whom there were other causes for achlorhydria
such as pernicious anaemia (Orlando 1973). Histological evidence (Palmer 1955,
Lodge 1955) pointed to the submucosa as the site of origin of the lesion, with only
secondary spread upwards to the epithelial surface - an unlikely sequence of events
if hydrochloric acid alone were to blame.
Animal studies also produced conflicting evidence. Ferguson (1950) showed the
damaging effect of acid alone on six species of animal oesophagus, including cats
and dogs. These studies were confirmed by Redo in 1958 and 1959, using a dog
model. However, a much quoted paper by Cross & Wangenstein (1957) suggested that
bile and pancreatic juice were the main factors causing oesophageal erosions in cats




By the 1960's concepts of aetiology were starting to crystallize. Treatment of
oesophagitis was firmly based on the acid/pepsin reflux theories of Hale (1957),
Redo (1959), Casten (1967), and Goldberg (1969). Medical treatment consisted of
antacids, anticholinergics, and sedatives, with surgery designed to reduce gastric acid
secretion, reduce and repair hiatus hernia and reconstruct the gastro-oesophageal
sphincter mechanism.
There was growing evidence however that this was insufficient to explain the
problems in all cases. Skinner in 1966 pointed out that there was little correlation
between symptoms and severity of reflux disease in many cases, and reiterated that
oesophagitis and its complications could occur in the absence of a hiatus hernia. With
the use of the investigations outlined above, there was therefore increasing evidence
that a large number of other factors were involved in creating the clinical picture of
oesophagitis.
Further studies in the 1970's and 1980's have increased our understanding of the
condition immensely, and these will be examined in more detail in the next chapter.
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Present views on aetiology
Non-reflux oesophagitis
Our modern concepts on the aetiology of oesophagitis are still far from
complete. Winkelstein's classification into four groups still holds true, but has been
modified. Trauma of a mechanical or caustic nature is a factor in some cases, and to
this we can now add drug induced inflammation (Heller 1982, Kikendall 1983,
Collins 1979, Bova 1987). Infection can still be a problem, although the organisms
have changed in the era of the antibiotic. Syphilis and Tuberculosis are rare, but
Candida albicans (Sheft 1970, Kodsi 1976, Mathieson 1983) can be a problem in the
debilitated patient, and Herpes simplex infection may be quite common in those who
are immunocompromised (Morrissey 1978, Shortsleeve 1981, Byard 1987).
Unlike the situation in the stomach and duodenum, there is little evidence that
Campylobacter pylori has any detrimental effect on oesophageal mucosa, although it
has been cultured from both healthy and inflamed oesophageal biopsy specimens
(Zimbalist 1988), and Barrett's oesophagus (Talley 1988, Hazell 1988, Paull 1988).
A "stagnant" oesophagitis, due to lactic acid produced by fermentation of food
debris, is certainly seen in achalasia, and above some strictures, but is not a serious
problem in itself (Smart 1987, Passmore 1975).
Crohn's disease of the oesophagus has been described (Gelfand 1968, Dyer 1969,
Freedman 1984, Geboes 1986, Maffei 1987), and oesophagitis may even rarely be




It is now accepted that the vast majority of cases of oesophagitis are due to the
effect of refluxing gastric contents on the oesophageal mucosa, either in the presence
or absence of an incompetent lower oesophageal sphincter (LOS). It is also accepted
that the symptom of heartburn may bear little relationship to either the presence of
oesophagitis or its complications. The aetiology of reflux oesophagitis can be
conveniently divided into two parts:
1.) Mechanical causes for reflux of fluid into the oesophagus (Fig 4).
2.) The mechanism of damage to the oesophageal mucosa.





















Oesophageal reflux occurs in normal healthy people. It is mainly post prandial,
and of short duration, due to rapid oesophageal emptying. It is usually, but not
always asymptomatic, and rarely occurs in the supine position (DeMeester 1976).
There is some evidence to suggest that it is not affected by advancing age (Spence
1985, DeMeester 1976, Sadek 1985), although oesophagitis is more common in the
elderly, possibly due to decreased tissue resistance, oesophageal motor function
(Eypasch 1988), and slower cell regeneration (McHardy 1972, Dodds 1981, Pries
1982).
Reflux becomes pathological when it produces undue symptoms, or signs of
oesophageal damage, and for thisto occur, one or more of the following mechanisms
must be compromised. Firstly, the antireflux mechanisms may be impaired, allowing
undue reflux to occur. Secondly, there may be decreased oesophageal clearance due
to motility dysfunction. Thirdly, the oesophageal mucosal protection mechanism may
be deranged.
Failure of protective mechanisms
The physiological protective responses to acid in the oesophagus are increased
frequency of swallowing (Orr 1984), with increased saliva production (Helm 1982,
1983, 1987) - a form of oesophagosalivary reflex in subjects with heartburn. The
opossum oesophageal submucosal glands have been shown to secrete bicarbonate
intraluminally, which may have a protective role, although this has not been shown
in man (Hamilton 1988).
These mechanisms may become deranged in patients with oesophagitis. For
example it has been shown that there is an age related loss of salivary response to
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oesophageal acidification, which may explain why erosive lesions are more common
in the older age group (Sonnenberg 1982, Helm 1987).
Although it was described some thirty years ago, the physiology of the main
anti-reflux mechanism - the lower oesophageal sphincter (LOS) - is still not fully
elucidated. Much of the work has been performed on the opossum sphincter, which
physiologically, is similar to that of man. It is thought that there are two main
elements to the generation of resting sphincter pressure. Firstly, there is a calcium
dependant low membrane potential in LOS smooth muscle (Fox 1978), which
produces an intrinsic myogenic tone not affected by neurotransmitter blocking agents
such as tetrodotoxin (Goyal 1976, Daniel 1976). Secondly, there is also a neural
element. Dividing the vagi in the opossum causes sphincter hypertension, and
stimulating the distal ends cause sphincter relaxation, suggesting that the neural
control is mainly inhibitory (Rattan 1974).
In the cat, excitatory and inhibitory pathways have been reported (Gonella
1977). Martin in 1986 showed that transient LOS relaxations could be abolished in
dogs by vagal blockade, although there was no effect with atropine. This suggests
that there may be both cholinergic and sympathetic pathways involved. Hormonal
mechanisms have also been explored, with emphasis on the pharmacological effects
of pentagastrin, which has been shown to increase sphincter pressure (Giles 1969).
The physiological effects of gastrin, however, have been shown to be negligible
(Sturdevant 1974, Higgs 1974, Dodds 1975).
Until recently, low resting LOS tone was the major factor implicated in
allowing reflux to occur (DeMeester 1976, Dodds 1982, McCallum 1986, Kahrilas
1986). The length of the sphincter zone, and the length of the intra-abdominal
segment of the oesophagus are also important in determining gastro-oesophageal
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competence (DeMeester - unpublished data, BSG 1988). Welch confirmed in 1982
that the diaphragm also has its part to play in the anti-reflux mechanism of the
sphincter zone.
There are other ways in which it is now thought thatthe LOS mechanism fails
to prevent reflux. Firstly, inappropriate, or transient total relaxation of a normal
sphincter is known to occur as a separate entity from the physiological relaxation
seen associated with swallowing (Dent 1980, Wyman 1984, Dent 1988). This has been
shown to be under vagal control in dogs (Martin 1986). Secondly, transient rises in
intra-abdominal pressure can overcome either a normal or low pressure sphincter
(Dodds 1982). It is now thought that physiological reflux is independent of sphincter
tone, and is instead the result of these transient inappropriate sphincter responses.
They may also be relevant in pathological reflux. In 1987, Kruse-Anderson
suggested that inappropriate responses are more likely to occur after non-propagated
contractile activity of the oesophagus, and are more often related to non-propagated
waves in those with severe acid reflux. Also in 1987, Gill showed that reflux is more
likely to occur during fasting in relation to the gastric component of the migrating
motor complex (MMC), which is known to increase intra-gastric pressure. The
relative importance of low resting pressure and transient falls in LOS pressure is not
yet known. One of the problems encountered when measuring sphincter pressures is
the large variation in normal levels (Russell 1987), but mean LOS pressures have
been shown to be lower in refluxers than non refluxers (DeMeester 1976, Dodds
1982).
Hiatus hernia - a common finding in patients with severe oesophagitis (Edwards
1973) - may predispose to reflux in some individuals because the extrinsic
diaphragmatic support for the LOS is reduced. In 1987, Mittal suggested that part of
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the reason for delayed oesophageal clearance in reflux patients was that gastric
contents are retained within a hernial sac, and reflux back into the oesophagus as the
LOS relaxes, so delaying the overall acid clearance time. In 1988, he suggested that a
reflex diaphragmatic contraction occurs as well as increased LOS tone in response to
increased intragastric pressure.
There are a number of other factors involved in increasing the exposure of the
oesophagus to gastric contents. In 1963, Siegel noted that acid perfusion of the
oesophagus in patients with heartburn induced motor abnormalities, and more
recently, these have been described by Kjellen (1985) and others (Baldi 1985,
Maddern 1986 & Kahrilas 1986), all of whom showed that in patients with
oesophagitis, motor activity was impaired, with slower clearance of oesophageal
contents. In vitro studies on cat oesophagus have shown that oesophageal acid
perfusion decreases LOS muscle tone (Biancani 1984), although this has not been
shown in man. More recently still, Eriksen (1988) has questioned whether the
oesophageal motility disorder is secondary to reflux, and has suggested that it may be
a primary disorder leading to reflux, rather than an effect of reflux.
Acid in the oesophagus has been shown to stimulate increased gastric acid
secretion (Ward 1970, Giles 1968), with a greater response in patients with severe
reflux disease. Most recently, Mulholland (1988) has shown in a small group of
reflux patients, that basal acid secretion may also be raised.
Smart in 1986, suggested that in some cases there may be a more widespread
motility disorder present, and that there is a relationship with the irritable bowel
syndrome.
The role of delayed gastric emptying in patients with oesophagitis is
controversial, but has been described in up to 57% of reflux cases (McCallum 1981).
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Keshavarzian (1988) has shown that although delayed gastric emptying is common in
refluxers, it is not well correlated with the degree of reflux present. There is
conflicting evidence that pyloric incompetence may also be involved in increasing
bile reflux (Kaye 1974, Matikainen 1981, Krog 1982).
Gastric distension has been shown to increase the frequency of LOS relaxations,
with a greater frequency of relaxations in those patients with oesophagitis (Holloway
1985).
The sensory pathways in the oesophagus which lead to the above reflexes
occurring are still poorly understood (Howard 1988). It is known that there are
mechanoreceptors, thermoreceptors and chemoreceptors present in the oesophageal
mucosa, and that most, but not all are under parasympathetic control. A few
mechanoreceptors excite sensory pathways passing through dorsal root ganglia in the
cat, and are almost certainly sympathetic in origin (Christensen 1984).
The pH sensitivity of the oesophageal mucosa in man remains unproven, and
indeed, a recent study by Thompson (1988) showed no difference in oesophageal
clearance response in human volunteers following acid or normal saline infusion.
Extrinsic factors
Extrinsic factors are also implicated. The most important of these is undoubtedly
cigarette smoking. Nicotine has been shown to reduce LOS pressure and predispose to
gastro-oesophageal reflux (Dennish 1971, Staniciu 1972, Schindlbeck 1987). Smoking
has also been shown to delay gastric emptying of solids (Miller 1987), and decrease
the neutralising effects of saliva, leading to reduced oesophageal acid clearance
(Gupta 1988).
Dietary constituents can also have an adverse effect on sphincter competence.
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Fat lowers sphincter pressure (Nebel 1972), and leads to increased postprandial
reflux (Becker 1988), and so do caffeine, chocolate (Dennish 1972), and the
carminative oil containing foods such as onion (Mellow 1988), garlic and peppermint
(Chernow 1979).
Alcohol not only reduces upper and lower oesophageal sphincter pressures
significantly, but also produces impairment of peristalsis (Hogan 1972).
In 1983, Clouse suggested that psychiatric illness may have a detrimental effect
on oesophageal motility.
The effects of psychological stress on oesophageal motility have been studied
only in the last few years, and so far resultsare contradictory, with Richter (1987)
showing increased amplitude of oesophageal waves induced by stress, and Soffer
(1988) showing no abnormalities of oesophageal contraction, induced by the same
stressful stimuli.
The mechanism of damage to the oesophagus
Acid
When gastric fluid is allowed to remain in contact with oesophageal mucosa for
a prolonged period, damage occurs. Historically the noxious agent is acid, and most
of the studies throughout the 1950's and 60's (Ferguson, Casten, Giles, Goldberg, all
quoted in Ch 1) pointed to hydrochloric acid and pepsin as the guilty agents. Few
papers, some of which have been mentioned, questioned this, and the belief is still
widespread today, despite growing evidence that acid is only one of several factors





The noxious qualities of bile were first noted in the late nineteenth century by
Rywosch on a number of different tissues, including those of the gastrointestinal
tract, in animals. It is now thought that some of his results may have been due to
laboratory artefact.
Smith in 1914, showed that bile would damage mucosal surfaces but evidence of
specific damage to oesophageal mucosa did not begin to accumulate until within the
last 25 years. Levrat, and Lambert in 1962, showed that diverting duodenal juices to
the oesophagus of rodents produced a severe oesophagitis, although they implicated
pancreatic enzymes as the major damaging factor. Davenport, using a dog model, in
1968 demonstrated the disruption of gastric mucosal cell membranes by lOmMolar
bile salts, and showed increase flux of Sodium and Hydrogen ions was occurring.
Indirect evidence for bile reflux occurring in hiatus hernia patients was given
by Gillison in 1969, when he demonstrated duodenogastric reflux occurring in a
large proportion of cases. He carried out some studies on monkeys in 1972, and
produced severe oesophagitis and stricture formation by enhancing gastr¬
oesophageal reflux of bile. Henderson, in 1972 and 1973, produced similar results in
dogs by oesophageal perfusion with bile, and bile salt/acid mixtures. Further clues as
to a mechanism of damage were given by Safaie-Shirazi et al. in 1975, They used
ionic permeability of oesophageal mucosa to hydrogen ion as a measure of mucosal
damage, and demonstrated, first in dogs, and then in man that perfusion of acid, and
to a greater extent bile/acid mixtures caused massive increases in mucosal
permeability. Similar work showing the toxic synergism between acid and bile has
been performed by a number of other workers using a rabbit or dog model (Chung
1977, Harmon 1978, Kivilaakso 1980, Lillemoe 1982, 1983, Kidder 1983,
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Schweitzer 1984, Lalyre 1984, Kiroff 1987).
In 1978, Pellegrini, using pH monitors, confirmed the presence of alkaline
reflux in man, and emphasised the importance of mixed acid and alkaline reflux.
Other aspects of bile damage have also been studied. Bachir in 1976 refined
Bernstein's original test and showed that mixtures of bile and acid produced far more
symptoms than acid alone, although this is contrary to Pellegrini's findings.
Hopwood in 1981, and Bachir in 1982, demonstrated the cellular disruption
caused in human oesophageal mucosa, using bile acid solutions. Salo in 1984
pinpointed the cell membrane and intracellular organelles as the areas primarily
damaged by bile.
The biochemical mechanisms are now also being studied. Biancani showed in
1984, in the cat, that calcium pathways of oesophageal sphincter muscle are
disrupted by acid perfusion. More recently still, in 1987, Manning has shown that
calcium homoeostasis is massively disrupted in the oesophageal mucosa of rabbits by
bile perfusion. He also found an analogy with the human condition in that it was the
deeper layers of the epidermis (Stratum germinativum) which were damaged first due
to their higher concentrations of calcium sensitive phospholipases. Also in 1987,
Kiroff produced similar findings using the rabbit model, showing damage to the
deeper layers of the oesophageal mucosa occuring first, in response to acidified
taurocholate solutions.
Disruption of calcium metabolism would also be expected to have effects on the
calcium mediated intrinsic LOS muscle tone, and in 1988, Szewczak has produced




The effects of trypsin on the oesophageal mucosa are not so well documented,
but were recognised as far back as 1951 by Cross, and by Lambert in 1962. The most
interesting recent data on trypsin comes from Lillemoe again. In 1983, he showed
that in rabbits, trypsin perfusion at an alkaline pH (7.5), produced oesophageal
mucosal erosions and ulceration without significant changes in hydrogen ion flux
across the mucosa. This suggested a different mechanism of damage to either bile or
hydrochloric acid. The most likely effect is a proteolytic action on the epithelial
surface itself, rather than on the deeper layers of the mucosa.
There is indirect evidence that lysolecithin may also be toxic to oesophageal
mucosa. Duane, in 1980, showed that this was significantly more damaging to gastric
mucosa than bile acid mixtures, producing large sodium and hydrogen ion
transmucosal fluxes.
In conclusion
From the above review, the evolution of oesophageal investigations can be seen
to have accelerated sharply in the past twenty years, and with it, our understanding
of reflux disease has deepened and broadened. However, as with all new
investigations, fresh insights into the pathophysiology of a disease inevitably pose
new questions. As the "gold standard", 24hour pH studies tell us a great deal about
acid reflux, and possibly something about alkaline reflux, but very little about reflux
of the actual constituents of gastroduodenal fluid. Correlation between acid reflux,
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and either symptoms or endoscopic findings has been shown to be poor (Johansson
1986). Bile, thought to be damaging to the oesophagus, cannot be measured easily by
pH study unless its pH is above 7, and the range of pH for bile reflux is an unknown
quantity. Any alkaline pH reading has also to be differentiated from swallowed
saliva. The way in which 24hour pH studies are assessed is also far from
standardized, with a number of different indices being used.
This thesis will develop the theories which have been discussed and following an
epidemiological review, will examine present techniques of 24hour pH testing, and
look at the different ways of interpreting the data. In particular the various indices
in present usage will be compared with a more statistically exact measurement - the
area under the curve. The limitations of pH testing will be examined and delineated,
with emphasis on the inability to measure bile reflux. Bile salts, and the pancreatic
enzymes in refluxate will then be examined in more depth. As little information is
available on bile in the human oesophagus, direct measurements will be undertaken
with a view to establishing a range for concentration and pH.
As direct aspiration techniques are inappropriate for long term monitoring,
methods of indirectly measuring bile reflux will be investigated in the subsequent
chapters with emphasis on the use of portable gamma probes to measure
radioactively labelled bile reflux. In this way it is hoped that a new technique may
be developed enabling ambulatory bile monitoring to be performed.
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Oesophagitis - a clinical review
The importance of oesophagitis in late twentieth century medical practice cannot
be emphasised enough. To illustrate this point, the upper GI endoscopy records in the
Portsmouth region between 1983 and 1988 have been examined. The results of these
examinations have been comprehensively stored on a dedicated computer database
(Micromed System).
A total of 12,652 examinations were performed up until March 1988. Of these,
8445 were new referrals, and it is from this group that the following figures were
obtained. In 1,928 cases (22.8% of the new patient total), a diagnosis of oesophagitis
was made (including Barrett's oesophagitis). This compared with 1,573 cases of
gastritis (18.6%), with only 777 duodena! ulcers (9.2%), and 504 gastric ulcers (6%).
There were also 254 benign oesophageal strictures (3%) and 247 cases of benign
ulceration (2.9%). (Fig 5).
When examined by decade (Fig 6), oesophagitis was most commonly diagnosed
in the 60 - 70 age group, and the actual numbers diagnosed in the 5th, 6th and 8th
decades were very similar. There was a steady increase in the incidence of the
disease from the second decade (14.7%) to the eighth decade (26.6%), with a
decreased incidence in the over 80's, which may in part be a reflection of the lower
number of patients endoscoped in this age group (Fig 7).
These data show that oesophagitis is the commonest disease of the upper
gastrointestinal tract seen at endoscopy. It also suggests that although there is an




The figures represent only the tip of a very large iceberg of disease, as a
significant proportion of patients will be treated only by their General Practitioner,
or by self medication, and a further unspecified number of asymptomatic cases will
remain undiagnosed and untreated in the community.
Assessment of reflux disease is at present performed not only by endoscopy, but
by intra-oesophageal pH testing, and the effectiveness of this technique will be
evaluated in the following chapter.
Figure 5
New Endoscopic Diagnosis of
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24 hour pH monitoring - the state of the art
Introduction
Monitoring of intra-oesophageal acid reflux using pH electrodes and recording
equipment is now the "gold standard" (Silverstein 1980) against which all other tests
for reflux have to be compared. It is itself, however, far from standardised, and has
certain drawbacks. Schindlbeck, in an outstanding paper in 1987, showed sensitivities
as high as 93.3% and specificities up to 92.9% for 24 hour pH testing using
percentage time pH < 4 as the only criteria, and other recent studies (Johnsson
1987a) have shown similar results. However, when one examines the protocols in
detail, one finds varying criteria for normality, and abnormality. These and similar
studies tend to select subjects from the extreme ends of the health/disease spectrum
in order to obtain statistical differences between "normal" and "abnormal" groups, and
produce high sensitivities and specificities. In particular, by excluding from the
normal range those with only occasional symptoms of heartburn, or the asymptomatic
volunteer with erythema at the lower end of the oesophagus, it is possible that one
may be artificially skewing the normal range for pH values towards zero. For
example Schindlbeck takes as his normal subjects those with no symptoms of gastr¬
oesophageal reflux, excluding even those with occasional symptoms, while Johnsson
added a normal endoscopy to these already strict criteria. Schindlbeck's abnormal
subjects were selected on symptoms alone, and a number had normal endoscopies.
Johnsson's on the other hand, all had proven grade II or III oesophagitis as well as
reflux symptoms.
The vexing question of what is, and what is not normal is particularly difficult
to answer when severe disease does not correlate well with symptoms, and equally,
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symptoms do not always point to actual disease being present.(Johnsson 1987b)
As in many other conditions there is no doubt a continuous spectrum from the
normal to the diseased state. Donald, in The Lancet in 1987, described diagnostic
yields for oesophagitis from 24 hour pH testing of 47%, and in a general hospital
setting, these figures probably represent a more realistic expectation.
As a way of comparing a patient's response to therapy pH testing may not be
accurate, as it has also been shown that there is a large inter-test variability for
individual patients (Wiener 1987, Donald 1987). Shorter testing intervals, using 12
hours or a post-prandial sample also have a lower diagnostic yield (Bianchi 1985).
The pH test will give information about the time exposure of the oesophageal
mucosa to acid reflux. It does not, however, tell us anything about the response of
the mucosa to the acid (Vitale 1984, Branicki 1984) has shown, along with many
other centres, that an abnormal pH test does not correlate well with abnormal
endoscopic findings or hiatus hernia. Going one step further than this, Lacey Smith
(1989) has shown no correlation between oesophageal pain, and acid reflux episodes.
The reason for this remains obscure, but it does strengthen the hypothesis that other
factors are involved in the condition.
The most obvious problem with a pH probe is that it will only measure the pH
of fluid in the lumen of the oesophagus, and therefore tells us nothing about the
volume, or the exact constituents of either refluxate, or swallowed material. It is also
possible that luminal pH does not accurately represent pH at the mucosal surface,
which may be different due to the effects of surface mucus and saliva. As these
factors may all be relevant to the aetiology of oesophagitis, any results obtained on
pH data alone may in some cases be severely compromised.
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Positioning a tube in the oesophagus is itself unphysiological, and has been
claimed to decrease oesophageal pH (Vinnik 1964). However the frequency of
swallowing has also been shown to increase with intubation (Evans 1985), thereby
reducing the duration of reflux episodes. Salivation may also be increased, with a
consequent increase in intra-oesophageal pH.
Having outlined the many drawbacks of the procedure, it is clear, however, that
pH testing will give a higher diagnostic yield than other tests of oesophageal
function such as manometry, endoscopy/biopsy or barium studies, when used alone,




There are two main types of electrode in use. Firstly the combined glass/reference
type (Fig 8), in which a glass and integral KC1 reference electrode are housed in the
same assembly, and secondly a monocrystalline antimony type, which utilises a
separate silver/silver chloride cutaneous reference electrode. Both types are reliable
if handled correctly, with the antimony one showing a slightly inferior performance,
and shorter working life due to corrosion of the metals used (McLauchlan 1987).
They may both soon be superseded by electrodes based on plastic (Evans 1987,
Rawlings 1985, Oesch 1986), Vanadium, or ISFETs (Ion sensitive field effect
transistors - Duroux 1988).
Positioning
pH recordings are arbitrarily taken from a point 5cms above the lower
oesophageal sphincter, as measured by manometry. Other techniques for placing the
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probe such as using the acid/alkali junction (Dehn 1986), or an endoscopic
measurement, are less accurate (Stoker 1987). Some workers have suggested that the
positioning is not important (Walker 1986, Dehn 1987), but recent evidence suggests
that, as in the stomach, there is a concentration gradient for gastric contents between
distal and proximal oesophagus (Crumplin - bile 1974, Sondheimer 1987, Shaker
1987, Cravens 1987), which wowld certainly account for the fact that oesophagitis
tends to be a distal oesophageal disease. It has now been well proven that out¬
patient, ambulatory monitoring is both more physiological, and more accurate in
predicting abnormality, as well as saving on hospital in-patient facilities (Branicki
1982, Falor 1980, Schlesinger 1985).
Interpretation
There is controversy over how the results of the test are to be interpreted, and
these hinge on the exact definition of a reflux episode. There are a number of
scoring systems in use. DeMeester, in 1980, described a scoring system based on six
different criteria of reflux, each criteria being weighted according to its sensitivity
for determining reflux. A final score was obtained by adding the weighted values
together. This had the advantage of high sensitivity and specificity, but the
disadvantage of being unwieldy. It was also based on small numbers of hospitalized
"normal" subjects, whose actual results were not normally distributed.
In 1984, Branicki introduced a frequency/duration index, based on mean
frequency, and mean duration of reflux episodes. This was easy to calculate, and
produced good discrimination between normal subjects, and those with reflux. It has
the theoretical disadvantage that if there are a large number of short repetitive
crossings of the pH 4 threshold (as are often seen on testing), then overestimation of
mean frequency, and underestimation of mean duration is likely to occur.
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Jenkinson, in 1987, described the use of percentiles to express his normal range
for pH testing, and showed high degrees of sensitivity and specificity, but the
technique has not found favour in gastroenterology circles.
The simplest measurement of acid reflux,and the most commonly used today, is
the cumulative acid index, which is the percentage time during the test that the pH is
less than 4. Schindlbeck's paper in 1987 showed that this is in fact more accurate
than any of the other scoring systems in discriminating between normal and
abnormal. All of these indexes differentiate between reflux occurring in the erect,
and the supine positions, with supine reflux being a more sensitive indicator than
erect.
The cumulative acid index is purely a measure of the time to which the
oesophagus is gxposed to acid. It tells us nothing about the volume of acid present,
and will not for example differentiate between exposure of the oesophagus to fluid
of pH 3.8, or a more acidic, and possibly more damaging solution of pH 1.2.
Aims
As a logical extension to the concept of the cumulative acid index, it is
proposed to examine the area under the curve on the graph of pH against time, and
more specifically to examine the area under the pH 4 line (Fig 10). This should
literally add depth to the former index, indicating the degree of acidity as well as
the time exposure of the oesophagus to acid. The hypothesis is raised that, if acid is
the only factor involved in the production of oesophagitis, the Area of the curve
under the pH 4 line should be a better predictor of abnormality than the Cumulative
Acid Index.
As well as studying the area under the curve, it is proposed to examine the
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cumulative acid index, and a number of other variables in normal subjects, and those
with reflux disease to decide on the best criteria for differentiating between normal
and abnormal.
Method
A full medical history was obtained, and a symptom questionnaire (DeMeester
1980, Greatorex 1983, see Appx 1) was filled in for all participants giving a score
of 0 to 9 for reflux symptoms.
Normal subjects were a volunteer group, who had no history of gastrointestinal
disease, and were allowed a symptomatic score of 0 or 1. As most of the adult
population experience occasional heartburn, this was not therefore an exclusion from
our normal group. Patients were a consecutive group being investigated for reflux
disease or atypical chest pain with a normal exercise ECG.
Most patients underwent upper gastrointestinal endoscopy with the Olympus Q10
endoscope, and a visual grading for oesophagitis was obtained, using a modified
grading based on Savary and Miller.
Modified Savarv and Miller grading of oesophagitis
Grade 0 - Normal oesophagus.
Grade 1 - Minimal oesophagitis - Non-confluent erosions just
proximal to mucosal transition zone.
Grade 2 - Moderate oesophagitis - Confluent, non-circumferential
erosions.
Grade 3 - Severe oesophagitis including ulceration - Confluent,
circumferential erosions, and/or ulceration.
Grade 4 - Benign stricture formation.
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The procedures were not all performed by the same operator.
45% (53/118) of patients also had biopsies taken. Initially it was planned to give
all biopsies a histological grading, but this proved impractical for two reasons.
Firstly, not all endoscopists remembered to take biopsies, and when biopsies were
taken, they were often insufficient in number, or not taken from the exact area of
oesophagitis. Secondly, as the Q10 endoscope has only a narrow biopsy channel, the
specimens were small and rarely included the lamina propria and submucosa, which
is necessary for accurate grading. None of the normal volunteers underwent
endoscopy.
Manometry technique.
With each subject, prior to passing the pH electrode, oesophageal manometry
was carried out in order to ascertain the exact position of the lower oesophageal
sphincter (LOS). 1% Xylocaine jelly was used to anaesthetise the nasopharynx, and a
4mm diameter triple lumen manometry catheter passed into the stomach. The catheter
contained three lateral openings at its distal end, with a 120° radial orientation to
each other, and being situated 5cms apart. The tube was attached via pressure
transducers (Lectromed Type 524-1) to a triple perfusion pump (Perfusor VI, B.
Braun). A perfusion rate of 1ml per minute was used. Recordings were taken on a
chart recorder (Lectromed MX6), calibrated to 2.5mmHg per millimetre, with a
chart speed of 50 divisions per minute.
Having taken basal pressure measurements from the stomach, the catheter was
withdrawn in 1cm increments, remaining at each point for approximately one minute.
In this way the lower oesophageal sphincter was mapped using the station pull-
through technique (Dodds 1976). Measurements of wave amplitude, duration and




The 24 hour pH test
Prior to use, all pH testing equipment was calibrated at room temperature, using
phosphate buffer solutions of pH 1.67, and 6.97.
Following accurate mapping of the position and length of the LOS, and
withdrawal of the manometry catheter, the pH electrode was passed via the nose into
the stomach, and then gently withdrawn to be placed 5cms above the upper margin
of the lower oesophageal sphincter. The position at which the pH readings altered
from gastric acidity to oesophageal neutrality (Acid/Alkaline junction) was also
measured, in cms from the external nares. The wire was passed behind the ear and
beneath clothing to prevent snagging, to the recorder carried on a waistbelt.
Two types of equipment were used. The principal type was a Radiometer GK
280IC combined glass pH electrode attached to a Novo Memolog™ 2A solid state
portable 24 hour recorder, with a 12Kbyte memory. This translates to 12,000 data
points, with a capability of sampling at 7.5 second intervals for 24 hours. The
electrode is 4.5mm in diameter, with a length of 25mm. The cable is of 2.5mm
diameter low noise coaxial type, 2.5m in length.
In some patients a Digitrapper Mk.II with antimony electrode was used. This has
a 24kByte memory, enabling a 4 second sampling interval to be used. In order that
the measurements be kept as physiological as possible, patients (initially fasted
overnight) were allowed to carry out normal daily work or leisure activities during
the test, and were allowed to eat and drink normally apart from dietary restriction
on foods of pH <5 and >7 about which guidance was given in the form of a list of
forbidden foods (Appx 2/Jenkinson).
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All subjects were asked to refrain from smoking, and taking antacid
preparations during the test period. H2 receptor antagonists were discontinued 2 days
prior to testing. During the test each patient kept a log (Appx 3) of activities
including eating, drinking and sleeping, as well as recording symptoms as they
occurred.
Processing of data
At the end of the 24 hour period, the pH electrode was withdrawn and
recalibrated in buffer solutions as above. The information was fed via an RS232
interface unit into computer memory (Ericsson PC). This could then be processed and
numerical and graphic hardcopy obtained using an attached printer (Mannesmann
Tally MT85). All data was backed up onto floppy disc, with two copies made, and
stored on different sites. The basic data on the printout for the two types of recorder
were similar-
Graph of pH against time, also showing event markers.
Total time of reflux
Cumulative Acid Index (% time below pH 4 during 24hours)
% reflux while erect.
% reflux while supine.
Total number of reflux episodes
Duration of longest reflux (sees).
Although two sets of computer software were used (Vertec and Synectics), the
criteria for a reflux episode was the same for both. A reflux was defined as starting
when the pH fell below 4, and finishing when the pH had risen above 5 again. In
this way, small fluctuations around the pH 4 mark could not produce artefactual




Figure 9 - Normal and Abnormal pH graphs.
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The Area under the Curve
By writing our own additions to the Basic program on the Vertec software, and
using a modification of Simpson's rule, the total area of the graph under the pH 4
line (Fig 10) and the erect and supine areas under pH 4 were also calculated. The
mean pH was measured also.
Simpson's rule requires division of the area to be measured into an even number
of vertical strips, of height y (Fig 10). By adding the sum of the areas of each strip
together, the total area can be obtained. The narrower the strip, the more accurate
the calculation.
The summed area = h (y-^ + yn + 4 ye + 2 yQ) .
Where h = width of each strip (the smaller this is, the more accurate the result)
ye = sum of all even ordinates
Yq = sum of all odd ordinates, leaving out and yn.
All relevant patient data, manometric data, pH data, endoscopic, and




Figure 10 - AUC and Simpsons Rule
The Area of the Curve
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207 combined manometry/24 hour pH tests were performed by the author.
There was a 7.7% failure rate for the procedure. 4 patients (1.9%) failed to tolerate
the pH electrode, while in 12 patients (5.8%) equipment malfunction led to
artefactual recordings.
10 patients who underwent testing while on H2 receptor blockers, and 22
patients who did not undergo endoscopy were excluded from the statistical
calculations.
118 patients, and 41 normal subjects were therefore included in the study. The
male:female ratio for the normal group was 25:16, and that of the patients was 64:54.
There was no significant difference in the sex ratios (Chi squared = 2.823, p> 0.1).
The mean age of the normal subjects (±SD) was 34 ± 11.4, and that of the
patients was 49.4 ± 15.0. There was a statistically significant difference between the
two means (p< 0.001). There was however, only a very weak correlation between
age and CAI (r = +0.185 p<0.05), and the age difference between the two groups was
therefore thought to be of little importance.
pH electrode drift.
The Radiometer glass electrode was checked for drift over 24 hours by
calibration before testing, and recalibration afterwards. Buffers of pH 1.68, and 6.97
were used at room temperature. Mean drift (± SD) at 1.68 was +0.28 (1.96 ± 0.59)
and mean drift at 6.97 was +0.02 (6.99 ± 0.19) These are within acceptable limits for
pH testing, and will lead to only a very minor reduction in CAI/AUC measurements.
The Synectics antimony electrode was calibrated before each recording, and
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showed little change over the 24 hours, as long as the electrode was polished with
fine emery paper initially.
Positioning of the oH electrode.
pH probes should be placed in a reproducible anatomical position in the
oesophagus in order to make valid comparisons between patients. The acid/alkaline
junction (AAJ) is often used to determine the position of the LOS when placing
oesophageal pH probes if manometry is not available. I have examined 125 subjects,
comparing the manometrically determined position of the LOS with the AAJ. The
techniques used to map the LOS and AAJ have already been described.
The mean (±1SD) length of the LOS was 3.5cm ± 1.3 (Range l-7cms). In most
cases there was a rapid change from pH 1-2 to pH 6-7 within 1cm. The AAJ
occurred within the sphincter zone in 72 subjects (57.6%). In 34 of these subjects the
transition was at the lower end of the sphincter. In 53 cases (42.4%) the AAJ fell
outside the manometrically determined LOS by 1cm or more. 44 (34%) cases were
below the LOS (Range l-13cms, mean 3.4 ± 2.3), while 8 were above (Range 1-
6cms, mean 2.8±1.8).
The variability of the AAJ in relation to the LOS makes it an unreliable
technique for accurately placing pH probes. The probable reasons for this are pH
changes in the fundic gas bubble (Emde 1987), and the occurrence of acid reflux
during withdrawal of the pH probe through the sphincter zone.
Mean oesophageal dH.
The mean oesophageal pH (±SD) over 24 hours was 6.00 ± 0.33, using the 24




Multivariate analysis of two groups of data was performed, to ascertain which
criteria were most useful for the discrimination between normality and abnormality.
For this purpose, only those patients with endoscopically proven oesophagitis (n =
73) were included in the abnormal group (i.e. those with an endoscopic score of 1 -
4). The normal group consisted of the volunteer subjects with a symptomatic score of
0 or 1 (n = 41).
A full description of the statistical method and results is included in Appendix
4, but the following is a list of the variables tested:
1.) Cumulative acid index (CAI%)*
2.) Erect CAI*
3.) Supine CAI*
4.) Area under the curve (AUC)
5.) Erect AUC
6.) Supine AUC
7.) Total number of reflux episodes (Reflux)
8.) Duration of longest reflux (Length)
9.) Smoker or Non-Smoker
10.) LOS pressure (Pressure)
11.) Endoscopy score
12.) Symptom score
Some items of data (*) were loge transformed to fulfil the statistical functions




Using multivariate analysis (Appx 4), it was shown that there were significant
differences between the controls and patients using the criteria (variates) Reflux,
Length, Pressure and CAI%. The bestdiscriminators between normality and
abnormality were CAI% and Length. Combinations of two or more variates did not
increase the discriminatory power of the test. Results of the normal and abnormal pH
tests are presented as a cumulative % graph in Fig 11.
There were similar numbers of smokers in the control and patient groups, and
this therefore had no discriminatory value when tested.
The Area under the Curve
When the variate AUC was added to the equation, it was found that it had a
very similar discriminatory value to CAI%. It was not a better discriminator between
normality and disease than CAI%. Fig 12 is a cumulative % graph showing the results
of normal and abnormal subjects in whom AUC was measured.
Endoscopy ggorg
The variates CAI%, Length, Reflux, Pressure and AUC were compared for the
group of patients with minimal oesophagitis (Endoscopy score 1) and those with
moderate to severe disease (Endoscopy score 2 - 4). It was not possible to
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Erect and Supine data
Because of the skewness of the Erect and Supine data, this was not used in the
multivariate analysis, but in a separate non-parametric test, the separate erect and
supine CAI% data were both good discriminators between control and patient groups.
The smaller amount of Erect and Supine AUC data was not tested.
Conclusions
As in a number of other studies, the Cumulative Acid Index has proved to be
the best discriminator between normality and disease, although there was a
considerable overlap between the normal and abnormal results. Acid is therefore an
important factor in reflux disease. However, despite the fact that AUC gives a better
indication of the degree of acid exposure, it is not a better discriminator for the
presence of reflux disease than CAI.
If the degree of acidity is no more important than the time of acid exposure,
then reflux at, for example, pH 3.8 should be just as damaging as reflux at pH 1.2.
The pH of refluxing fluid depends on the amount of acid present, and on
neutralizing alkalies such as food, saliva (pH 5.45 - 6.06 - Pellegrini 1978), bile and
the pancreatic secretions. This study therefore suggests that these factors may have a
role to play in the production of the disease.
The poor correlation between the pH test results and endoscopic findings may
indicate a fault with either the pH testing technique, or endocopic assessment but it
does confirm Branicki's similar findings in 1984, and also tends to reinforce the idea
that factors other than acid are involved in the disease process.
The endoscopy scores were deliberately kept simple, and as only a few
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experinced endoscopists were involved, it is not thought likely that major errors in
interpretation were made.
If the pH test itself is at fault, then a patient's true reflux status is not being
reflected. Some problems with the technique have already been highlighted, but that
of reproducibility has only been touched upon. There are few studies of the day to
day variations in pH test results. Donald (1987) showed the magnitude of reflux
varying by up to a factor of two in six patients undergoing repeat tests. Wiener
(1987) showed variations up to a factor of 3.2 in 46 patients. Conversely, Johnsson
(1988) showed a reproducibility of 77% in 20 patients undergoing 2 pH tests on
consecutive days. Undoubtedly, testing each patient on several occasions and taking a
mean would produce a more accurate result for an individual patient, but this would
be unacceptable to most patients, and would be very time consuming. The problem of
reproducibility can be overcome to some extent by using large numbers of patients.
For this pH/endoscopy correlation study 71 subjects were used, and this is thought to
be a large enough number for valid interpretations to be made.
The results of these pH studies are dependant on the the efficacies of the tests
themselves, but the evidence presented strongly suggests that constituents of
oesophageal refluxate other than acid are contributing to the overall picture, and
these will be examined in more detail in Chapter 5.
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The constituents of oesophageal refluxate.
With the advent of 24 hour pH testing, much is now known about acid reflux
into the oesophagus. The evidence outlined in previous chapters suggests that bile and
enzymes may also be important in the aetiology of reflux disease, although little is
known about the amounts present in the oesophagus, or their patterns of reflux.
Bile salts are normally present in the human stomach with mean concentrations
varying from 50 to 500microM/l, and ranges up to 9mM/l (Table 1). In patients with
upper gastrointestinal disease, mean gastric bile salt concentrations tend to be
somewhat higher, and they are highest in patients who have undergone gastric
surgery where they can rise to 19mM/l (Table 2). There is a shallow concentration
gradient of bile salts between the pylorus and the oesophagus (Crumplin 1974), but it
is still reasonable to conclude that the levels of bile salts in oesophageal refluxate
should bear a close relationship to stomach levels.
There is very little data available on intra-oesophageal bile salt levels during
reflux, and no work has been performed on the pH of such material. Smith, in 1984,
used a four hour continuous aspiration technique to obtain samples of oesophageal
refluxate in 40 patients with known acid reflux, and showed mean bile salt
concentrations of only 8.9microM/l with a range of 0-100microM/l. More recently
Mittal showed negligible bile salt levels in oesophageal samples from 16 patients with
oesophagitis. In 1988, Gotley used a Salem sump aspiration method to measure bile
salts in 50 patients with reflux disease. He found levels in excess of 200microM/l in
25% of his series. Also in 1988, Johnsson, in Sweden, showed low levels of bile salts
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in continuously aspirated samples of oesophageal reflux, varying from 0.8 to 64
microM/1 (mean 9.6microM/l).
Apart from the work outlined above, this the full extent of the literature on
oesophageal bile concentrations, and clearly is inadequate. Bile salts in the range of
100 - 200microM/l have been shown to be damaging to oesophageal mucosa, when
mixed with acid, by Hopwood, and Bateson. In 1988, Gotley showed cytopathic
changes to in vitro samples of human oesophagus with bile salt levels as low as
50microM/l. This range of levels appears to be well within physiological limits in
the stomach, but needs further investigation in the oesophagus.
The "raison d'etre" of this thesis is to investigate new ways of evaluating
oesophageal reflux, but it was thought necessary to also examine bile reflux using a
variation on the more conventional aspiration method, in order to ascertain the range
of levels likely to be encountered in our subjects.
Both the proteolytic pancreatic enzymes (Levrat 1962, Mud 1982, Salo 1988)
and also pepsin (Goldberg 1969, Kivilaakso 1980) have been implicated in the
causation of reflux oesophagitis, but their presence in human oesophageal reflux has
not been quantified. Therefore, in order to confirm their presence in human reflux,
tryptic and peptic activity were also measured.
Total serum conjugated bile acid assays are available, and have been used
successfully on gastro-oesophageal aspirates. The studies by Smith and Mittal were
based on continuous suction sampling of the oesophagus over periods varying from
30mins to 4 hours, with the resulting samples being assayed. It is possible that this
technique may be diluting any bile present, due to swallowed saliva, and intermittent
reflux of non bile containing gastric secretions. Mittal's results were affected by the
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presence of food, which produced bile acid-like activity in his assay.
It is difficult to obtain satisfactory samples of oesophageal reflux, due to its
intermittent and unpredictable nature, and the dilution effects mentioned. At
endoscopy, bile stained fluid is quite commonly seen lying in the oesophagus, often
in relation to oesophagitis, or a hiatus hernia. In order to avoid the problems
outlined, direct aspiration of oesophageal fluid was undertaken via the suction
channel of an endoscope for total bile salt assay, trypsin assay, pepsin assay, and pH
measurement.
In the following chapters, the measurement of radioactively labelled bile reflux
with gamma probes will be discussed. In order to ascertain the levels of radioactivity
likely to be encountered, selected patients with known reflux problems were given
75SeHCAT lOmicroCi orally 24 hours prior to routine endoscopy, and aspirates were
counted for 75SeHCAT as well as being assayed for bile salts. By using known
standard concentrations of SeHCAT it was then possible to calculate a specific
activity for 75SeHCAT in bile.
The bile assay used was based on an enzymatic, colorimetric system for
quantitation of bile acids in serum (Enzabile, Nycomed (UK) Ltd.). 3 Alpha-
Hydroxy-steroid dehydrogenase (3 Alpha-HSD), in the presence of NAD oxidises
hydroxy bile acids to their corresponding 3-keto steroids under formation of NADH
(Fig 13). A yellow tetrazolium salt Nitro Blue is reduced to its coloured formazan in
the presence of NADH. Formazan is blue, with a maximum absorption at 540nm.
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Tables 1 and 2
TABLE 1
INTRAGASTRIC BILE ACID CONCENTRATIONS
IN NORMAL SUBJECTS
MEAN QtM/l) MAX <//M/l)
Rhodes et al. 100 680
1969
Crumplin et al. 120 580
1974
Goldner et al. 500 2,300
1976
Dewar et al. 51 112
1982
Poxon et al. 430 9,370
1986
TABLE 2
INTRAGASTRIC BILE ACID CONCENTRATIONS
IN UPPER G! DISEASE
























Due to the sensitivity of the test, and the large variations in expected bile
concentrations in oesophageal aspirates, most aspirates were diluted with Bovine
serum albumen (BSA, Ortho Diagnostic Systems, 22% protein concentration and used
in a 1:10 dilution with N Saline (22g/litre)) prior to testing to keep within the range
of the test standards. BSA has been shown to enhance the reactivity of the enzyme 3
alpha-HSD from Pseudomonas testosteroni (Scholmerch), and is the same diluent used
for the bile standards used in the assay. BSA contains measurable quantities of bile
acids, and prior to setting up the procedure BSA was run through the assay on its
own to assess the efficiency of the industrial bile depletion process (alcohol
fractionation). Negligible amounts of bile acid were found in the BSA concentration
used of 22g/l. Collins has shown that the pH of the sample does not affect the
outcome of the assay, due to the buffering effect of the reagents used.
Method:
Oesophageal sampling was performed on 51 patients undergoing routine
endoscopy either at the Royal Naval Hospital, Haslar, or at Queen Alexandra
Hospital, Cosham. Gastric samples were aspirated from a further group of 17
patients. The procedures were performed by myself, and other gastroenterologists.
The patient lay in the left lateral position, and intravenous Midazolam or
Diazemuls (5-10mg) was administered. Prior to intubation the suction channel was
flushed with water and then cleared and dried with air. No suction was performed in
the oesophagus prior to sampling. When bile stained fluid was seen within the
oesophagus or a hiatus hernia following a straightforward intubation which did not
involve excessive retching, a sample of the fluid was taken. The endoscope used in
most cases was the Olympus Q10. An endoscopic grading of oesophagitis was
performed using the modified Savary and Miller grading described in Chapter 4.
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Samples were collected into a sputum trap, connected in series with the suction
apparatus. Usually between 2 and 20mls of fluid was obtained.
The pH of each sample was tested using a Standard pH Meter (Radiometer
Copenhagen, PHM82). The samples were then spun down in a centrifuge for fifteen
minutes to remove any contaminants and solid material, prior to freezer storage at
minus 20°C.
Total bile salt levels, tryptic activity and peptic activity were then measured in
batches of 12 to 18. For the Bile salt estimations, depending on the colour of the
specimens, 1:11, or 1:51 dilutions were found to be most appropriate using BSA as
above. 1:100 dilutions are considered to be the maximum practical using the Enzabile
kit, and these were only necessary in samples taken from post-gastrectomy patients.
The bile salt assay
This was a manual procedure, performed by myself, and consisted of adding
500microl of buffered enzyme to 200microl of paired samples (BSA diluted), with
500microl blank reagent added to identical paired samples. Three bile standards
(again paired) were run through with each assay (5microM/l, 25microM/l and
lOOmicroM/l). In order to calculate intertest variability, one paired patient sample
was repeated for each assay. After mixing, cuvettes were incubated at 37°C for 15
minutes. A "stop" reagent was then added (500microl of 0.1M/1 HC1) to arrest the
enzymatic process, and the absorbance of samples tested in a colorimeter (LKB 2074
Calculating Absorptiometer) at a wavelength of 540nm. The mean absorbance of the
paired samples was then taken as the final reading. Bile salt concentrations were
calculated using a standard curve.
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Figure 13 - The Enzabile reaction







The trypsin assay was also based on an enzymatic, colorimetric method, first
devised by Lundh in 1957. The assay is based on the principle that trypsin can act as
an esterase, and hydrolyse benzoylarginine ethyl ester (BAEE) to benzoylarginine.
This reaction can be monitored directly by measuring the increase in absorbance at
253nm which accompanies the formation of benzoylarginine.
The assay was performed at standard pH 8, using a Lambda 5 spectrophotometer
(Perkin Elmer), by the Department of Chemical Pathology at Queen Alexandra
Hospital, Portsmouth. lOmicrol samples were added to 3mls BAEE and incubated for
3 minutes at 30 C, and the change of absorbance at 253nm measured over this
period. Trypsin standards were run through with each assay. Trypsin activity is
proportional to the change in absorbance, and can be calculated using a standard
curve, in IU/1.
Normal levels of trypsin in duodenal aspirates are greater than 10IU/1
(Bramwell Cook 1967, Murthy 1980).
The pepsin assay
The pepsin assay was developed at The Royal Naval Hospital, Haslar, and is a
kinetic method based on the degradation of albumen complexed with bromphenol
blue (BPB). Pepsin degrades the complex, releasing increasing quantities of dye, with
a colour change which can be measured colorimetrically (Gray 1982).
This assay was performed using a centrifugal analyser (Cobas Bio, Roche), in
the Department of Biochemistry at The Royal Naval Hospital, Haslar. 20,^1 samples
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were added to 200,J of albumen/BPB substrate, and incubated at 37°C for Sminutes.
The change in absorbance at 605nm is measured at 10 second intervals over this
period, and is proportional to the pepsin activity of the sample.
Mean peptic activity in samples taken from the normal stomach (including
stimulated and unstimulated periods) is 62IU/1 (Deakin 1985).
Gamma counting
Six patients had taken oral 75SeHCAT 24 hours previously. Samples (lOOmicrol)
from these patients were counted on an automatic gamma counter (Gamma Master
1277 - 10 head version) as well as undergoing chemical assay. In this way
concentrations of radioactivity could be measured in the samples, as compared with
standard dilutions of SeHCAT. This fulfilled two purposes. Firstly, it enabled me to
obtain accurate quantitative measurements of radioactivity in refluxed material in
microCi/ml, in order to put numerical values on the sensitivity range of both the
internal and external probes. Secondly it enabled me to obtain a specific activity for
SeHCAT, from which, theoretically a total body conjugated bile pool size could be
obtained.
Statistical Analysis
Bile salt concentration and tryptic activity were correlated with pH using
standard linear regression analysis and Student's t test. Oesophageal samples from
post gastric surgery patients were compared with the remaining oesophageal samples,
and also gastric samples, using one way analysis of variance (See Appendix 4).
Patients were also divided into two groups. Group A with an oesophagitis
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grading of 0 or 1, and Group B with a grading of 2, 3 or 4. Multivariate analysis
was performed on the two groups using the three variables pH, peptic activity and
tryptic activity, utilising the 2-sample Hotelling's T2 statistic (Hotelling 1931) in
order to examine the relationship of the variables to severity of oesophagitis.
Results.
Study numbers
Fifty one oesophageal samples were taken, and 17 gastric samples. Eight samples
were excluded from the oesophageal correlation studies as the patients had undergone
gastrectomy or a gastric drainage procedure.
In 32 out of the 43 patients (74.4%) with intact stomachs, there was related,
macroscopic oesophagitis. Due to limited volumes of specimen, one patient sample




As the bile salt assay was a manual technique, within run, and between run
analysis was performed.
The standard error of the difference between two means (SEDM) was calculated
for 50 paired samples, measuring the absorbance of each sample. The two means
were 1001.11 nm and 993.65nm. The SEDM was 7.31. There was therefore no
significant difference between the two means for the paired samples (p >0.3), and
intra test variation was insignificant.
Seven runs were performed, with a sample of known concentration in each run.
The coefficient of variation between tests was 4.7%, which is acceptable for a steroid
assay.
The standard curve was linear within the range of bile concentrations used (r =
+0.998, Fig 14)
Bile
There was a positive correlation between bile salt concentration and pH (r =
+0.427, p <0.002, Fig 15). Twenty-one out of the 43 samples fell in the pH range 4
- 7. Bile salt concentrations are shown in Table 3.
Trypsin
Forty two samples were assayed for trypsin. The levels ranged from 0.1 -
19.6iu/l, with a median of 1.5iu/l. There was a strong positive correlation between
tryptic activity and pH as shown in Fig 16 (r = +0.589, p <0.001).Twenty-one out of




Forty samples were assayed for pepsin, with a range 1 - 250iu/l, and a median
of 27iu/l. Linear regression analysis was not performed on these results, for reasons
which will be explained, but the results are shown graphically in Figure 17.
Specific activity of 75SeHCAT in bile
Six patients had previously taken oral 75SeHCAT, and samples were counted in
an automatic gamma counter to compare with standard dilutions of 75SeHCAT.





















Figure 14 and Table 3
Bile Standard Reference Curve
(5, 25, and 100microM/l)
Absorbance (540nm)
microM/l















pH MEAN (±1 SD) 4.2(±2.0) 5.8(^1.8) 3.3(±2.1)
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Figure 15 - Graph Bile
pH and Concentration of
Oesophageal Bile
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This study was performed in order to ascertain the probable levels of bile salts,
tryptic activity and peptic activity likely to be encountered in oesophageal refluxate.
The technique of endoscopic aspiration is not one that has been used before, but for
our purposes it is thought to be valid. Although the reflux seen may not be totally
physiological, i.e. it may in some cases be secondary to intubation - it nevertheless
will have the same constituents as true reflux, and at worst represents levels and pH
of bile seen in the fundus of the stomach during the fasting state.
Bile Salts
The wide range of bile salt concentrations reported here are greater than those
previously found in the oesophagus. However it does tend to bear out the hypothesis
that bile salt levels in refiuxate should be similar to levels in the stomach. The levels
reported are well within the range which can cause oesophageal mucosal damage,
which was evident in 74% of the endoscopies.
The highest levels encountered are comparable with hepatic duct bile salt levels
(10 - 20mM/l, pH 7.8 - 8.6), but not gallbladder bile (50 - 200mM/l, pH 7 - 7.4)
(Ganong 1979)
It can be seen that the bile salt concentrations in the post surgery samples were
considerably higher than in the remainder, and they were also more alkaline. There
were significant differences between the mean values of oesophageal samples from
the post-gastrectomy group, and the intact stomach group. There was no significant
difference between the mean values of the oesophageal samples/intact stomach group




Duodenogastro-oesophageal reflux is often described as "alkaline reflux", but
these results suggest that this is a complete misnomer. Bile salts were found in
samples throughout the pH range from 1.5 to 7.8, with the mean pH being 4.2. Only
a very small proportion of the samples had a pH above that found in the normal
lower oesophagus (Normal pH 6.00 ± 0.33).
The accepted level below which acid reflux is measured during pH monitoring
is pH 4. Alkaline reflux has also been measured in this way using pH 7 - 7.5 as the
lower limit. 49% of the above samples, on bile salt assay, and 50% of samples on
trypsin assay fell into the range between pH 4 and pH 7, and so would have been
totally missed as reflux episodes, by a standard 24 hour pH test, despite their
potentially damaging nature. The results suggest therefore, that pH testing is very
insensitive to bile/trypsin reflux, and emphasises the need for a separate way of
monitoring what seems to be a common phenomenon.
From the previous chapter, it could be seen that there was a considerable
overlap between the normal and abnormal ranges for pH tests, and one of the
reasons for this could well be the potentially damaging "missed" bile reflux between
pH 4 and pH 7.
Trypsin
Pancreatic enzymes have been implicated in the aetiology of oesophagitis, and
we have therefore measured trypsin as being a representative enzyme in our samples.
There was very little enzyme activity when the pH of the aspirate was below 4. This
was to be expected, as trypsin is inactivated at acid pH. There was a strong positive
correlation between increasing pH, and increasing trypsin activity, and the highest
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enzyme activity levels were seen when the pH was above 6.
In some samples, trypsin activity was very low, even when the bile
concentrations rose above ImM/l. This may in part have been due to enzyme
degradation occurring during freezer storage, especially in the lower pH range.
It is unlikely that trypsin plays any part in the production of oesophagitis, when
reflux is acid. However, when duodenal contents reflux into the oesophagus in higher
concentrations, and the pH is also higher, tryptic activity can approach that in the
normal duodenum, and may lead to a form of autodigestion of the oesophageal
mucosa.
Pepsin
The results of the pepsin assay are more difficult to interpret, and linear
regression analysis was not thought to be a valid test on these measurements. Small
numbers of endoscopic specimens were collected weekly over a several month
period, making freezer storage necessary, although it is known that this may lead to
enzyme degradation, especially when the pH is below 1.5 (Deakin 1984). This has
almost certainly lead to artefactually low peptic activity in many of the samples in
which the pH was low. This can be seen on the scattergram (Fig 17), where there is
a cluster of low readings in the pH band 1-2. There is a further cluster of low
readings when the pH is above 5, and this is due to physiological inactivation of
enzyme in the alkaline pH range.
There are two reasons justifying presentation of the results of pepsin assay.
Firstly, pepsin has not been measured before in the oesophagus, and secondly, despite
the underestimates caused by storage artefact, peptic activity was still found to be
present above pH 4, in the area missed by pH testing.
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There are at least seven pepsin isoenzymes (Etherington 1967, Samloff 1969),
some of which are active in the higher pH bands. Little is known about the ratios of
pepsinogen 1, and the other isoenzymes. It may be that some patients with
oesophagitis have higher concentrations of the higher pH band isoenzymes (Ref -
personal communication - S Gray).
Peptic activity was in most samples inversely proportional to pH, and
gastric levels were seen in a number of cases, where the pH was below 5. The
proteolytic nature of this enzyme again makes it a possible factor in the causation of
oesophagitis.
Endoscopy Score
We have shown no correlation between the degree of oesophagitis and
concentration of bile salts, tryptic activity or pH in oesophageal refluxate. This
suggests that other factors, such as the sensitivity of the oesophageal mucosa to




In practice, there are a number of factors which make measurement of specific
activity inaccurate using oesophageal sampling. The main variable is the
physiological ± life of 75SeHCAT, which although on average is about 2.4 days, is
unpredictable between patients, with a normal seven day retention range varying
from 15-80%. The amount of retained 75SeHCAT would need to be measured
immediately prior to aspiration of the sample to overcome this problem.
Another variable is much more difficult to quantify. On spinning down each
sample, there appeared to be a green residue which was thought to consist of food
residue. However a sample run through the gamma counter produced a higher
reading for radioactivity than it's supernatant, showing that it contained ,5SeHCAT
labelled bile. It is likely that this residue contained mainly dissolved bile salts mixed
with it, but also small amounts of precipitated bile salts, the amount of precipitate
depending on the acidity of the sample. The more bile salts are precipitated the
lower the concentration of remaining bile/radioactivity there is to be measured in
the supernatant. As concentrations are low, this makes specific activity readings
unreliable. For the accurate measurement of total bile salt pool, these measurements
would be better carried out on duodenal bile, or gallbladder bile.
Due to the problems outlined above, specific activity of 75SeHCAT in the
samples varied, although three samples were of comparable activity. It is clear
however from these measurements that there are only very small amounts of
75SeHCAT in bile reflux, as is only to be expected, when the oral dose is as low as
10>iCi, most of which will be distributed in the small bowel and gallbladder at any




It has been shown that at least three potentially damaging agents are present in
oesophageal reflux other than hydrochloric acid. Enzyme activity is pH dependant,
and it has been shown that in the relevant pH bands, gastric and pancreatic enzymes
are often present in sufficient quantity to cause damage.
Bile reflux is often described as "alkaline reflux", but these results suggest that
this is a misnomer. Bile was found in samples throughout the pH range, with the
mean pH being 4.5. Only a very small proportion of the samples had a pH above that
found in the normal lower oesophagus.
Half of these samples would have been missed as reflux episodes by
conventional oesophageal pH-metry. These results therefore cast some doubt on the
true value of pH testing for measurement of the reflux of duodenal contents into the
oesophagus, and suggest that further techniques are required for the separate
monitoring of bile and trypsin.
In Chapter 6, a new concept in measurement of bile reflux will be described.
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The external detection of gamma labelled bile
"We have examined the hypothesis that a portable external gamma probe, placed
over the sternum, facing the oesophagus, can be used to measure radioactively
labelled bile reflux."
Introduction.
Having ascertained that bile reflux cannot usefully be measured using presently
available techniques, the above hypothesis was raised.
Radioactive labelling of bile has been used for diagnostic purposes for some
years, but the techniques all use whole body counters or gamma cameras rather than
portable equipment, to detect gamma emissions.
Oesophageal reflux has been detected using scintiscanning techniques (Fisher
1975 & 1976, Kaul 1985 & 1986), but these have all involved ingestion of a 99Tcm
labelled colloid, rather than using an intrinsically labelled bile acid. Radiolabeled
bile has been detected in the stomach (Nicolai 1980), but has not been looked for in
the oesophagus.
Small portable solid state gamma detectors based on Cadmium Telluride have
been available in the clinical field for some time (Walford 1973, Entine 1974), but
have not been widely used. They have been shown to be effective in detecting early
loss of renal function following transplant surgery (Smith 1981), but until now, have
not been used to detect radiolabeled bile.
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By combining radiolabelling techniques with portable gamma monitoring
equipment it is hoped that a more accurate method may be developed for the
measurement of bile reflux, in the ambulatory subject.
Aim
The aim of this chapter is to combine the techniques outlined above, and to
ascertain whether the new method will accurately measure bile reflux. The possibility
of combined pH and gamma monitoring will also be examined.
More specifically, the sensitivity of an external gamma detector will be
examined with reference to radiolabeled bile, initially in a phantom model, and then
in human subjects.
Prior to human studies, certain basic information had to be obtained, and
techniques needed to be developed.
Firstly a suitable radiolabel had to be chosen, and a suitable gamma detector
obtained. The Memolog computer software discussed in the previous chapter had to
be adapted to read gamma counts either as a single data set, or as data in parallel
with pH monitoring. For program manipulation, I had the invaluable help of Dr Alec
Houston, Consultant Physicist to the Department of Nuclear Medicine, RNH Haslar,
and with his help, the necessary program modifications were made, and improved
upon, over the period of initial development of the technique.
Vertec Scientific, who provided me with the Memolog 600 System, were able to
provide a compatible, portable CdTe gamma detector.
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Before choosing a radiolabel, the relative advantages of 75SeHCAT and wTcffl-
HIDA were studied.
The Cadmium Telluride gamma detector
Cadmium Telluride (CdTe) is a complex synthetic semiconductor crystal, which
behaves in a similar way to a diode. It is energized by a bias voltage of 60-80Volts,
(unlike scintillator/photomultiplier tubes which need a bias voltage of 1500Volts).
Gamma photons hitting the crystal matrix produce small voltage alterations
technically known as "free drift of mobile holes and electrons" (Bell 1971, Sinclair
1986) which are directly proportional to the amount of radioactivity being measured.
Different crystals are sensitive to different photon energies, depending on the growth
characteristics of the crystal matrix, and also its dimensions. The larger the crystal
the more sensitive it is to the higher gamma energies. The range of detection for
CdTe crystals is from 20KeV up to 300KeV.
As very small currents are involved, in the region of nanoamps, the signal from
a crystal needs to be boosted by a charge sensitive preamplifier. Current is then fed
to an amplifier, which converts the signal from analogue to digital form for display,
or information storage purposes. Unlike scintillation detectors, CdTe will function
well at room temperature, and also at body temperature, making it ideal for
prolonged internal or external counting in human subjects.
The gamma detector available to me was purpose built for use with the
Memolog 600 system, and consisted of a 16mm diameter, 2mm thick disc of CdTe,
encased in a lead lined aluminium housing. Within the same housing, the CdTe




from the Memolog batteries, and signals from it were fed by 2 metres of coaxial
cable, back to the Memolog for storage in the ROM memory, in the same way as pH
data. Storing counts from a gamma detector in this way is a relatively new, but




1. CdTe CRYSTAL 6. LEAD COLLIMATOR
2. 1mm LEAD SHIELDING 7. STAINLESS STEEL HOUSING
3. 1mm LEAD SHIELDING 8. HEADPLATE
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1.) 75SeHCAT (Selenium HomoCholic Acid Taurine)
This substance is a synthetic bile analogue (Homocholic acid taurine) to which a
75Selenium label has been attached. It has been shown to behave in an identical
fashion to the naturally occurring bile conjugate taurocholic acid (Delhez 1982,
Merrick 1982), and mixes fully with the endogenous bile pool after oral ingestion.
At present it is used mainly as a test for bile malabsorption from the small bowel
(Nyhlin 1980, Meller 1981, Merrick 1985, Sciarretta 1986), and has also been used
to study faecal bile loss in non ileal disease (Van Tilburg 1987).
75Se has a physical half-life of 123 days, but although 75SeHCAT takes part in
the enterohepatic circulation, its biological half-life is only 2.6 days (Merrick 1982),
as in each pass of the terminal ileum, a part is lost into the colon and excreted.
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2.) 99Tcm-HIPA (Technetium N IminoDiacetic Acid)
99Tcra-HIDA has been used in the diagnosis of liver and gallbladder disease
since the late 1970's (Harvey 1975, Harvey 1979, Eikman 1979, Van der Linden
1984). It is another radiolabeled bile analogue (Loberg 1976) and is used routinely
as a test for gallbladder function (Eikmcn 1979, Van der Linden 1984), and has also
been used to examine duodenogastric reflux (Nicolai 1980, Mackie 1982). It is given
intravenously rather than orally, and is rapidly taken up by the liver, and excreted in
bile. A small proportion is also excreted by the kidneys. Unlike 75SeHCAT, it is not
reabsorbed by the terminal ileum, and so is quickly lost from the system. It also has
a far shorter physical half-life, of six hours. This means that considerably larger
doses of radiolabel can be administered without affecting the total absorbed radiation
dose (Brown 1981). The corollary of this is that it cannot be used for long term





Absorbed radiation dose to man for 75SeHCAT and "Tc^-HIDA
The higher recommended oral dose of 75SeHCAT (25microCi) is used here to
illustrate the maximum radiation dose in a healthy human subject. It is anticipated















In order to calculate the maximum absorbed radiation dose from 99Tcm-HIDA in
















The above figures can be compared with the "average total background radiation
dose to man" which is 0.257rads/year. The radiation dose received by the ovaries
during a standard oral cholecystogram is 0.078rads.
It can be seen, therefore, that despite the long physical half-life of 75Selenium,
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and the higher dose of 99Tcm, the absorbed dose of radiation from either compound
to subjects in this study is likely to be small and within the limits of background
radiation (Soundy 1982, Brown 1981).
Having compared the merits of the two radiolabels in common usage, 75SeHCAT
was chosen as most appropriate for monitoring of bile reflux. The absorbed radiation
dose is smaller, and it has the advantage of being given orally. It has a longer
biological half-life (T^biol) than 99Tcm-HIDA, mainly due to its property of being
reabsorbed in terminal ileum, and this would enable it to be monitored for a longer
period. 75SeHCAT has its main photon peak at 260KeV, as opposed to 140KeV for
99Tcm-HIDA. Both these energies are well within the range which can be measured
by CdTe detectors.
The high energy and long T^biol of 75SeHCAT are also the causes of its major
drawbacks. Firstly, the higher energy means less Compton scatter, and a higher
background count from tissues adjacent to those being studied. Secondly, the T%biol
of the compound in the human body means that it can only be given in microCurie
quantities to avoid overdose of radiation.
The remainder of this chapter is devoted to the experimental work with
75SeHCAT, performed to ascertain whether the hypothesis raised is tenable. It is
divided into three parts - initial phantom studies, clinical phantom studies, and lastly





The aim of this study was to ascertain the relative contributions of the liver and
oesophagus during a bile reflux test using 75SeHCAT. A simple model of the organs
in their anatomical positions was used (Fig 23). The model was immersed in water to
simulate soft tissue, and a gamma camera used to measure counts.
At this early stage in the work a large number of assumptions had to be made,
but using Soundy's data (1982), approximate tissue concentrations of 75SeHCAT could
be calculated, and also approximate concentrations in bile, using the levels obtained
in Chapter 5.
Mean concentration of 75SeHCAT in bile - 0.0084microCi/ml
Mean bile concn in oesophagus - 671micromol/l
Mean specific activity of 75SeHCAT in bile - 0.046microCi/micromol
»> Mean 75SeHCAT concn = 0.031microCi/ml of oesophageal bile.
Of a lOmicroCi dose of 75SeHCAT, only 4% is distributed throughout the body.
96% remains within the enterohepatic circulation. The liver retains 5%, while the
gallbladder on average retains 15%, although this must vary considerably, depending
on the volume of bile it contains. This leaves 76% in bile itself.
Assuming a liver volume of 1500mls, overall liver concentration will be
0.0003microCi/ml. The gallbladder will on average contain 1.5microCi of
75SeHCAT, but in the initial study, as the gallbladder is a considerable distance from




















A 5ml bolus of refluxing "bile" was assumed for the phantom, at a concentration
of 67 lmicromol/1.
Due to the large number of variables described, the "physiological" 75SeHCAT
concentrations in the model oesophagus were bracketed by a factor of 5 above and
below:
0.006microCi/ml in 5mls water (0.03microCi total)
0.03microCi/ml in 5mls water (0.15microCi total)
0.15microCi/ml in 5mls water (0.75microCi total)
Method
The liver model was filled with 75SeHCAT labelled water at a concentration of
0.0003microCi/ml. The "oesophagus", which consisted of a hollow plastic tube of
1.5cms internal diameter, contained 5mls of 75SeHCAT labelled water in three
different concentrations - 0.0006, 0.03 and 0.15microCi/ml.
The model described, was then placed up against a gamma camera (Siemans
Large Field of View, 37 ZLC head, with parallel hole, low energy, all purpose
(LEAP) collimator) in its vertical mode, with its centre exactly lOcms from the
"lower oesophagus".
Firstly, background counts were measured over a 90 second period. Counts were
then measured with the labelled liver model in situ. The oesophageal model was then
added with the three concentrations of 75SeHCAT described, thoroughly washing the
tube between measurements, and counts measured over an identical period.
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The following conclusions can be drawn from this experiment. Firstly, the
background count throughout is very high, and together with liver background adds
up to more than half the overall counts, even with the higher concentration of
75SeHCAT. The high background count may be due to the fact that the experiment
took place within the confines of the Department of Nuclear Medicine, in the
presence of other patients being scanned, and all further tests were performed
outwith the department.
Secondly, despite the high background count, adding increasing concentrations
of 75SeHCAT to the oesophageal model did in fact produce a stepwise increase in
counts.
The results suggest that even at the very small concentrations of "bile"





The aim of this second phantom study was to examine the sensitivity of the
external gamma probe to physiological levels of 75SeHCAT,using the same model as
above. At the same time a simple measurement of increasing volumes of "reflux" was
also performed.
Method
The portable gamma probe was placed exactly lOcms from the "lower
oesophagus" model, in the horizontal plane (Fig 23). For this experiment, a 2mm
thick straight bore single hole (7mm diameter) lead collimator was used. The gamma
probe was connected directly to the Memolog portable recorder for data collection.
For this experiment, five one minute sample intervals were used. As before,
background counts were initially measured, and counts were then measured with the
lcbelled liver model in situ. The oesophageal model was then added with increasing
volumes of 75SeHCAT, starting with 0.04microCi in 1ml of water, and serially
adding 1ml increments to a maximum of 5mls, to mimic reflux of between 1 and
5mls of bile containing fluid.
Results:
















































































Firstly, it was again clear that background levels of radiation accounted for a
significant proportion of all measurements, and that the liver model was also
producing a large contribution.
The experiment showed that the external gamma probe was capable of
measuring the small amounts of radiation present, and that it could also measure
incremental rises in "oesophageal" levels of 75SeHCAT.
The counts were very low in all cases, and it should be noted that results are in
counts per minute, rather than counts per second. It was noted during the experiment
that counts could be boosted by a factor of 10 by removing the collimator, at the
expense of losing a degree of directionality.




To examine the sensitivity of the external gamma probe to an oral dose of
lOmicroCi of 75SeHCAT in a human subject, using measurements over the small
bowel, liver and mid oesophagus.
Method
A 60 year old male subject was given a lOmicroCi dose of 75SeHCAT orally.
Five hours was allowed for absorption of the dose, and the uncollimated external
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gamma probe was then fixed to the anterior abdominal wall with adhesive tape, and
left in situ, with the patient ambulant, for 24 hours. The Memolog portable recorder
was used for data collection, using a sample interval of 15 seconds.
The position of the external probe was changed three times during the 24 hours,
in order to collect counts over the small bowel (3cms below umbilicus), liver (8th
intercostal space in mid-clavicular line) and oesophagus (mid-sternum). Mean counts
(in counts per second) were then calculated for each area.
Results
Shown graphically in Fig 26
Conclusions
This experiment confirmed the sensitivity of the uncollimated external gamma
probe to a standard dose of oral 75SeHCAT administered to a human subject. It also
showed a high gradient in counts between the three areas examined, suggesting that
directionality is maintained despite lack of collimation, and that background counts
over the oesophagus in a non bile refluxing patient are relatively low. From the
standard deviation measurements, and from the graphic printout, it was clear that
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As with the phantom studies, predetermined "physiological" amounts of
75SeHCAT labelled water were now measured in the human oesophagus.
CLINICAL STUDY 2
Aim
The aim of this study was to simulate bile reflux in a human subject, and to
further assess the directionality of the uncollimated probe. For this purpose, pilot
studies were performed, and a technique was developed in which a Fogarty catheter
and balloon containing a measured amount of 75SeHCAT could be passed down the
oesophagus, and into the stomach. Initially, it was not intended to simulate any of the
effects of background radiation produced by 75SeHCAT in the liver or small bowel,
but simply to assess the sensitivity of the external gamma probe.
Method
A normal subject first underwent oesophageal manometric pressure testing to
determine the position of the lower oesophageal sphincter (LOS). Having done this,
a Fogarty catheter (Size 10) was passed via the nose to position the balloon exactly
5cm above the LOS. Metal skin markers were then placed over the sternum and a
chest X-ray (plain pa) taken. In this way an exact surface marking was obtained for
the intra-oesophageal balloon, and the gamma probe could be accurately placed
facing it. The Memolog recorder was used to collect data from the probe.




The Fogarty catheter was then emptied as far as possible of air by applying
suction via a syringe/two way tap. It was found in pilot studies that a significant
volume of 75SeHCAT labelled fluid remained in the Fogarty catheter itself, and
added a "false background" level. This was also accounted for here by counting over
a "75SeHCAT primed" Fogarty, with the balloon empty. The catheter was filled with
a predetermined concentration of 75SeHCAT - in this case, 0.04microCi/ml -
without blowing up the balloon. Further background counts were then taken.
A 0.5ml, then 1ml increments of 75SeHCAT were sequentially injected into the
balloon up to a total of 0.2microCi (5mls). A 15 second sample interval was used for
measuring counts over a ten minute period for each increment. The procedure was
repeated, having moved the balloon 5cm down, to the level of the LOS, and then
again to a position in the fundus of the stomach, 5cm below the LOS.
Two problems were encountered with this technique. Firstly, the subjects tended
to experience some discomfort and tugging in the nose, when the Fogarty balloon
contained the fuli 5mls of fluid, caused by oesophageal peristalsis. Secondly, when
moving the collapsed balloon down to the cardia, and on into the stomach,
measurements were necessarily from the external nares, and on one or two occasions,
it is thought that coiling of the tip of the catheter may have taken place.
Results:




















































The above study showed stepwise increases in gamma counts as the amount of
75SeHCAT was increased in the Fogarty balloon. Moving the radioactive source out
of direct line with the probe produced a reduction in counts with the larger amounts
of 77SeHCAT. It is not immediately obvious why, with the lower concentrations, and
the gamma probe directly opposite the balloon, the counts dropped rather than
increased. One explanation is that the balloon may not have been properly aligned
with the probe due to looping of the catheter tip.
At this stage a problem became apparent. Although readings were being
obtained with the very small quantities of 75SeHCAT being used, when these were
compared with the counts obtained in Clinical Study 1 - a patient who had taken oral
75SeHCAT, it was clear that background readings over the oesophagus (50 - lOOcps)
were of a greater order of magnitude than the artificial reflux in the latter study (5
- 15cps).
With some interest, the effect of simulated bile reflux using the Fogarty




The aim of this study was again to simulate bile reflux in a human subject, and
to further assess the directionality of the uncollimated probe. The important





Three normal volunteers took part in this study. Twenty four hours prior to
intubation, each volunteer was given lOmicroCi of 75SeHCAT orally. Manometry, X-
Ray screening and Fogarty catheter intubation was then performed as before. A
higher incremental range of 75SeHCAT was used in the Fogarty catheter
(0.05microCi/ml), and six increments, up to a total dose of 0.5microCi in 5mls water
were measured with the probe facing a point 5cm above the LOS, and the balloon in
the three positions as before (LOS + 5cm, LOS, LOS - 5cms).
Results
Data obtained was comparable in all three cases, and results of one subject are
shown graphically in Fig 28.
Conclusions
As expected, background levels of radiation were considerably higher due to the
ingested 75SeHCAT in the liver, gallbladder and small bowel, and although counts
were higher as increasing increments of 75SeHCAT were injected into the mid-
oesophageal balloon, they were only really measurable above 0.4^Ci in 4ml water.
This represents 2.5-5% of the standard ingested dose - almost certainly too large a
proportion as studies in Chapter 4 have shown 0.01 - 1% is a more realistic
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The main problem highlighted by the above investigations is that counts from
the small quantities of 75SeHCAT which may be expected in refluxing bile are being
swamped by background from the liver, gallbladder, and small bowel.
There are a number of ways in which counts from labelled oesophageal reflux
may be selectively enhanced.
Increasing the directionality of the probe by collimation will tend to cut down
on liver and small bowel background, but in this case, the lead shielding reduced the
sensitivity of the probe to such a large extent, that the low levels of 75SeHCAT
present became almost immeasurable. Other workers have overcome this problem by
using a more sophisticated collimator, with up to 80 holes in the lead disc
(Washington 1988).
Angulation of the gamma probe upwards, away from the liver should also
decrease background counts, and in 10 subjects this was tested. A 30° angle was
found to decrease background counts by 30%. The probe was difficult to keep at the
required angle in ambulatory subjects, and in view of the small increase in
sensitivity, was felt to be impractical.
Gamma radiation obeys the inverse square law, and distance is therefore of
prime importance when measuring it. The oesophagus is a deep structure throughout
most of its length, and on measurements from 105 lateral chest X-Rays is an average
of 13.7cms from the skin overlying the mid sternum. The gamma probe could be
placed closer to the oesophagus in two positions.
Firstly, in the neck, where distance would be reduced to three or four
centimetres, and background radiation would also be reduced due to the larger
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distance from the abdomen. Unfortunately, there would be correspondingly less
reflux higher up in the oesophagus. This position is therefore not viable.
The second feasible position for the probe would be on the back, facing directly
forward. Rather surprisingly, X-Ray measurements showed that the lower third of
the oesophagus is almost equidistant from the skin overlying the sternum and
vertebral spines (A/P ratio 13.7 : 13.4).
Another important adverse factor was touched upon in Clinical Study 1. It was
noted during this 24 hour study that background counts from 75SeHCAT were not
steady, but fluctuated. The fluctuations in counts were of the same order of
magnitude as the 75SeHCAT artificial reflux, and could not be differentiated from it.
Fluctuations in gamma counts
Although not directly relevant to this thesis, the phenomenon of the fluctuations
in gamma counts is briefly discussed as it has not previously been reported.
The fluctuations in counts seen as background over the oesophagus were a
reflection of far larger fluctuations seen over the liver and small bowel. These were
too high to have been due to reflux, and were investigated as 24 hour studies, in 8
normal volunteers.
By comparing small bowel transit time of lactulose (The hydrogen breath test),
with the small bowel transit time of a 75SeHCAT capsule, as measured by a gamma
probe over the terminal ileum, it became clear that initial peaks in counts were due
to passage of 75SeHCAT through the small bowel, and that further peaks in counts
were due to the enterohepatic circulation of bile, together with gallbladder filling
and emptying (Stoker 1987).
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A further interesting finding was that in half the patients gamma counts dropped
below the mean and levelled out during sleep, suggesting that bile ceased to
circulate, and remained in the gallbladder. In the other half there were continuing
large fluctuations in counts overnight, despite the fasting state. This suggested that
bile continued to circulate during sleep in some subjects, while in others it did not.
The subject merits further study, as major differences in the enterohepatic
circulation may be relevant in a number of disease states such as bile malabsorption
diarrhoea and gallstones.
Summary
To reiterate the first paragraph of this chapter, the hypothesis that a portable
gamma probe, placed over the sternum, can be used to measure radioactively labelled
bile reflux, has been examined. The results of the above experiments show that the
hypothesis is non-tenable, using 75SeHCAT.
At this stage, two options were explored. Firstly, the above experiments could
be repeated using 99Tcm-HIDA as the bile label. The lower energy Technetium would
be expected to have higher tissue attenuation, and therefore, proportionately less
background effect over the oesophagus. At the same time, the milliCi doses of 99Tcm
given, would increase overall counts, and allow collimation to be used with an
increase in probe directionality.
The second, and more interesting option was to abandon the external gamma
probe in favour of a detector which could be placed within the oesophagus. In
theory, this would negate the directionality, and distance factors, as the measuring
instrument would be bathed in refluxing fluid.
These options will be combined, and discussed in the next chapter.
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THE DEVELOPMENT AND USE OF AN INTERNAL GAMMA PROBE
"We have examined the hypothesis that an internal gamma probe, placed within
the oesophagus, can be used to measure radiolabeled bile reflux."
Introduction
Many of the problems associated with use of the external gamma probe could be
overcome if the detector crystal was placed closer to the radioactive source, in this
case, radiolabeled bile salts. The most efficient way to do this would be to place the
probe within the oesophagus, so that readings were taken from the same position as a
pH probe, being intermittently bathed in refluxate. The hypothesis discussed in the
previous chapter was therefore modified to encompass this possibility.
Internal gamma probes have so far received very limited use in the medical
field. True internal probes have in fact only been used to trace bronchogenic
tumours labelled with 57Cobalt-bleomycin (Barber 1980). This was achieved by
passing a probe down the biopsy channel of a bronchoscope, and placing it, under
vision, adjacent to suspicious lesions labelled with radioactive tumour marker.
Small portable gamma probes have been developed for use during surgery
(Harvey 1981) and have been used to detect parathyroid adenomas (Ubhi 1984), and
osteogenic tumours (Szypryt 1986) per-operatively.
Internal gamma probes have never been used in gastrointestinal investigations,
and prior to testing the above hypothesis, a period of development was undertaken.
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Phase 1 - DEVELOPMENT
Specifications
As shown in previous chapters, the oesophagus forms a relatively hostile
environment for any measuring instrument, which will be intermittently bathed in
acid, bile, and enzyme mixtures, as well as food and saliva. The initial specifications
for such a device were as follows:
1.) Dimensions small enough to be passed nasally (maximum diameter 5mm).
2.) Durable, and waterproof to allow prolonged monitoring (up to 24 hours)
whilst being bathed in acid and bile.
3.) Cable of sufficient length to attach it to an external preamplifier.
4.) Sensitivity to 75Se and 99Tcm in the varying amounts previously noted in
refluxed bile.
Aim
The aim was to build a CuTe probe to these specifications, for use with the
Novo Memolog portable monitoring equipment. The requirements were discussed
with Radiation Monitoring Devices Inc. (RMD) of Watertown, Massachusetts, USA.
This is a small company with a unique knowledge of the production and use of
Cadmium Telluride gamma detectors. They are the sole commercial source for
crystals used in a multitude of fields throughout the world and it was they who
produced a 2.5mm diameter experimental probe for use in the lung. Collaboration
with thiscompany was arranged, and their laboratory and workshops in Boston, USA
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were visited, in order to view the equipment and its manufacturing process at first
hand.
The following is a description of the developmental problems encountered and
how they were overcome.
The probe
The dimensions of the probe were set at 5mm diameter - this being the
maximum that could be comfortably passed via the nose - and 14mm length. This is
approximately the size of an antibiotic capsule, and much the same size as a glass pH
electrode.
Complete electronic isolation from the gastro-oesophageal mucosa was deemed
essential, due to the fact that the Cadmium Telluride crystal was activated by a
voltage bias of 60 volts, albeit with a minute leakage current in the range 10 - 300
nanoAmps. It was therefore embedded in epoxy-resin, with a Teflon coated
aluminium casing. The probe was rounded at both ends to facilitate entry and exit
from the nasal passages. It was then rigorously tested in the laboratory in a fluid
environment.
A Cadmium Telluride crystal was picked for sensitivity to photon peaks at 140
and 260 keV, these being the peaks associated with ,JSe, and 99Tcm.
Collimation of a probe this size was not possible, but it was requested that a
small amount of lead or tungsten shielding be inserted into the nose of the probe, to
reduce background counts from the liver and small bowel - a problem previously
encountered when using the external probe.
The prototype CdTe oesophageal probe took three months to build, and the
result is shown diagrammatically in Figure 29. The crystal dimensions were 2mm x
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2mm - considerably smaller than the 16mm diameter, 2mm thick disc used in the
external probe. Only two major problems were encountered during its construction.
Firstly, the small size of the housing meant that there was no extra room for
lead/tungsten shielding, or for any form of vibration damping mechanism. Secondly,
on final testing the connections between the probe and its cable were found to be
weakened by any bending at the junction between the two. As this would be
unavoidable in passing the probe through the nose, extra strengthening was added at
this joint.
The probe and its cable assembly were capable of being sterilized chemically
for internal use.
The cable
To be sensitive, and to avoid problems with background noise, the length of
lead between the gamma detector and the preamplifier had to be as short as possible.
In the external gamma detector (Fig 18), the preamplification circuits were built in
to the shielded detector housing, with only a few millimetres between the two.
Increasing cable length leads to rising capacitance within the system, with reduced
signal to noise ratio. Even low inductance cable tends to act like an aerial, picking
up any extraneous electromagnetic radiation in the vicinity, and increasing
background electronic noise.
RMD advised that, ideally the cable length should be less than 50cms. This was
not long enough for oesophageal use, as to be placed in the lower oesophagus or the
fundus of the stomach, approximately 35 - 40cms of wire needed to be passed. A
compromise of 60cms of cable was decided upon. This still meant that the






(1) Not to scale.
(2) All dimensions in mm.
(3) Wire lead length 60cm.
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Due to the small size of the internal gamma probe, a built in charge sensitive
preamplifier was not feasible, and a separate external device was necessary. A
tailored preamplifier (Baxter 1976) could be supplied by RMD, with the prototype
internal probe, but this would not necessarily have been compatible with our
Memolog equipment. It was therefore decided to utilise the preamplifier stage of the
external probe, which was already compatible with the Memolog system.
On receiving the probe, it was initially connected to our external gamma
detector preamplifier, which was dismantled for the purpose. The internal probe was
found to function with these circuits after adjusting the voltage bias, and signal
threshold levels of the Gamma Module section of the Memolog. A convenient mount
for the preamplifier was made by utilising the housing and rubber cover for the
external detector too. This could easily then be stuck in position on a patient's neck,
shoulder or chest, depending on the length of lead available after passing the probe.
(For circuit diagram see appendix 5)
The power sources
For initial bench testing of the internal probe, the Memolog recorder batteries
provided the necessary power source for the preamplifier and crystal. At a later
stage, with an RMD preamplifier, a small mains driven power pack was purchased,
and later still, this was replaced by a portable battery pack.





The software developed for use with the external gamma probe was used with
little further modification for transferring and storing data from the internal probe.
Solving developmental problems
Following delivery of the prototype, it became clear that there were still several
problems to overcome. These stemmed from the different characteristics of the new
probe.
At rest on the bench with no radioactive sources close by, the probe produced a
variable amount of background counts. These were due mainly to electronic noise
induced in the crystal and its cable by a number of factors. CdTe crystals are
microphonic (they act as very effective microphones at certain frequencies), and
simply tapping the crystal housing produced increased counts. This microphonic
effect is brought about by the fact that the crystal is piezo-electric - that is, pressure
distortion of the crystal causes current to flow within it.
CdTe is also a semiconductor, and behaves like a radio diode. Moving the cable
through an electromagnetic field (e.g. past a mains lead) will induce current, as will
simply bending the cable. When the whole apparatus was immobile, concentrations of
75SeHCAT down to 0.0ImicroCi/ml could be detected, at levels 2-3 times natural
background levels, suggesting that in these very controlled circumstances the crystal
was sensitive enough for our purposes.
The effect of background radiation from small bowel and gallbladder 75SeHCAT
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were not accounted for initially.
Ways to overcome the above problems fell into two groups. Firstly, the
radioactive label could be changed to one of a lower energy ("Tc™ - 140KeV, or
even lower still 1251 - 20KeV). This would reduce actual radioactive background
counts, due to increased tissue attenuation, with a consequently higher signal to noise
ratio. Secondly, ways of reducing the inherent "noisiness" of the crystal/cable
assembly were examined, by altering signal threshold levels, and by considering
changing the cable itself for one with ultra-low inductance characteristics.
After consultation with the manufacturers, and after extensive electronic testing
by Vertec with their own preamplifier, the conclusion was reached that the more
advanced RMD preamplifier was needed. This was specifically designed to be
insensitive to the inductance of the cable, and the microphonics of the crystal, but at
the same time was capable of picking up a gamma photon induced signal from the
CdTe crystal. It had the disadvantage that it was a little larger than the Vertec
model, and for our prototype, was initially mains driven, making a fully ambulatory
system impractical.
The preamp/powerpack system purchased was equipped with several feet of
cable, so that subjects would be ambulatory around the bedside if necessary.
Further electronic modifications by Vertec were necessary to the CdTe Module
in the Memolog system in order to make it compatible with the RMD preamplifier.
Several adjustments were made to the voltage bias on the crystal, and the voltage
threshold levels on the module (which also contained pulse shaping circuits). The




The more sophisticated preamplifier proved an effective screen for extraneous
electronic noise produced by cable inductance, and crystal microphonics. This
enabled me to embark on phantom studies using the probe, to measure its in vitro
sensitivity prior to use in vivo.
Phase 2 - PHANTOM STUDIES
Study 1 - In vitro.
Aim:
The aim of the initial studies with the new probe was to assess its sensitivity to
75Se and 99Tcra.
From the previous bile salt studies, it was apparent that the detector had to be
sensitive enough to pick up between 0.01 and 1% of the administered radioactivity -
in the case of 75SeHCAT this meant in the range of 0.001 - O.lmicroCi.
Due to its smaller cubic capacity, the internal probe was expected to be less
sensitive to gamma photons than the external probe (i.e. it would produce less counts
per unit of radiation). In anticipation of this reduced sensitivity, the alternative
radiolabel, 99TcmHIDA was also examined.
Method:
A range of concentrations (microCi/ml) of 75SeHCAT and 99TcmHIDA in water
were prepared in test tubes (Volume 5mls). The internal gamma probe was placed in
each tube for one minute, using a 5 second sample interval, and the mean counts for




The probe proved sensitive down to concentrations of 0.ImicroCi/ml above
background counts for both 99Tcm and 75Se. Background counts consisted of natural
radiation, and electronic noise (Fig 30).
Conclusions:
With the RMD preamplifier, the overall sensitivity of the crystal to gamma
photons was slightly diminished, but it still proved possible to measure very small
doses of radioactivity. As previously explained, however, it was felt that 75SeHCAT
would not reflux in even these small amounts, and for reflux studies, a radioactive
label with better counting characteristics required. Technetium99in, in the form of
99TcmHIDA was a suitable alternative, and bearing in mind the advantages and
disadvantages discussed in the previous chapter, it was decided to continue in vivo















Study 2 - In vivo.
Aim:
To study probe sensitivity in the human oesophagus, in the presence of
systemically administered 99TcmHIDA.
Having assessed the probe in vitro, the next important step was to assess it in the
oesophagus itself. This was a more demanding test, with a number of other factors
coming into play. Firstly, the operating temperature of the probe would be higher at
37°C rather than room temperature. Secondly, the cable was unlikely to remain still,
due to neck and pharyngeal movements. Thirdly, the all important effect of
background radiation from systemically administered radiolabel had to be assessed.
Method:
A normal human subject underwent oesophageal manometry, to ascertain the
position of the lower oesophageal sphincter. The gamma probe was then passed via
the nose to a position 5cm above the upper margin of the sphincter, and taped in
position, with the preamplifier slung around the neck, and connected to the Memolog
recorder, using a 0.5 second sample interval.
Four milliCi of 99TcmHIDA were administered intravenously, one hour prior to
the test. Five millilitre boluses of pertechnetate (99Tcm04~) labelled water were then
swallowed by the subject at intervals. The concentrations used were 2microCi/ml,
5microCi/ml and lOmicroCi/ml. Two swallows were performed at each of the
selected concentrations.
With the probe still in position, a standard oesophageal transit study was then
performed, with the subject lying under a gamma camera, using a 1 milliCi bolus of
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99Tcm04* in lOmls of water.
Results:
On initially passing the probe, very high counts were recorded. This was due to
changes in the operating temperature of the probe. By reducing the threshold voltage
by a small amount, the probe could be brought back into the gamma detection range.
There were peaks in gamma counts after each pertechnetate swallow, which
could be seen above a low background count produced by radiolabel in the
gallbladder and small bowel. The peaks were small for the 2microCi/ml swallows,
and large for the lOmicroCi/ml swallows. Following the test, the patient regurgitated
a small amount of fluid, and this too was picked up by the probe - the first time an
actual reflux event had been monitored (Fig 31).
The gamma camera readings obtained from a region of interest over the lower
third of the oesophagus during the oesophageal transit study correlated well (visual
only) with readings taken simultaneously from the internal probe (Fig 32).
Conclusions:
The conclusion from these initial studies was that the gamma probe functioned
adequately in vivo, and was capable of monitoring very low levels of 99Tcm labelled
material, above background radiation from 99TcmHIDA in the liver, gallbladder and
small bowel.
The probe may also have a use in the measurement of oesophageal clearance,
having the advantage of portability, and the disadvantage that it will only measure
clearance from one "region of interest" at a time.
What these studies could not tell us was whether the probe would measure
dynamic bile reflux in a patient with known reflux disease. The third phase of this
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chapter will deal with measuring actual bile reflux events.
Figure 31
Internal Gamma Probe -
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Phase 3 - BILE REFLUX STUDIES
Introduction:
Having established that the probe functioned adequately in the human upper
gastro-intestinal tract, a number of patients with known bile reflux, and an equal
number of normal volunteers were examined.
Aim:
The aim of this study was to validate the measurement of pathological and
physiological bile reflux in human volunteers using the internal gamma probe.
In order to validate the readings taken from the probe, two parallel methods of
measuring reflux were performed simultaneously. Firstly, as with the oesophageal
transit test, simultaneous scintiscanning was performed, but with the camera centred
over the body of the stomach. Secondly, aspiration of refluxate was performed at 5
minute intervals, from the area adjacent to the probe, using a fine (8 French Gauge)
Ryles tube. This was taped to the gamma probe cable, to ensure specimens were
taken from as close to the crystal as possible. Fine tubing was found to be ideal, as it
easily passed with the probe, and enabled small specimens of 1ml to be taken for
separate gamma counting. Larger Ryles tubes were also tried, but could not be
passed along with the probe, and so the exact positioning of the tip in relation to the
probe was less predictable.
The feasibility of simultaneous pH monitoring was also explored. This was
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abandoned in favour of direct aspiration for the following reasons. Firstly, there did
not appear to be any correlation between acid reflux, and peaks in the gamma
readings - a finding which was not unexpected in view of the results described in
Chapter5. Secondly, it was not practical to pass an aspiration tube, pH probe, and
gamma probe simultaneously.
It was initially hoped to perform all validation studies with the probe in the
lower oesophagus. However, during test runs in patients with known severe bile
reflux, it became clear early on that this would be very inefficient. Even the severe
oesophageal refluxers, when under test conditions, lying under a gamma camera,
would not reflux to order.
Various techniques were tried to enhance reflux, including Valsalva manoeuvre,
abdominal binders, and raising the foot of the bed. The results of this were
unpredictable, and unphysiological. Reflux of bile into the fundus of the stomach
was found to be a far more predictable phenomenon. In practice the furthest the
probe could be passed with the length of cable available was 10 - 15cms below the
LOS. For the patient's comfort, and for reproducibility, the studies were all
performed with the probe placed 5cm below the manometrically determined LOS.
Method:
Patients and normal subjects underwent identical procedures. A total of ten
examinations were performed. The first three patients were bile refluxers, as shown
on endoscopy (PB, ED and LA), and were pilot studies to assess the optimum position
for the probe, and the feasibility of performing simultaneous pH monitoring.
Each subject was fasted for 12 hours prior to testing. Any drugs affecting
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gastric secretion (antacids, H2 blockers) were stopped 24hours prior to the
procedure.
The nasal passages were anaesthetised with 1% Xylocaine jelly. Oesophageal
manometry was performed to map the LOS. The gamma probe, previously sterilized
by soaking in 1% Gigasept, with attached aspiration tubing or pH electrode, was then
passed via the nose into the oesophagus or fundus of the stomach and positioned as
described above. The cable/tube assembly were taped to the nose, and the cable
connected to the preamplifier, powerpack and Memolog with the subject supine,
under a gamma camera (Siemans Large Field of View, 37 ZLC head, with parallel
hole, low energy, all purpose (LEAP) collimator). For aspiration purposes a sterile
lOcc syringe was attached to the tubing.
A counting interval of 5 seconds was used for the internal probe, while the
scintiscanner counted over 15 second intervals.
The reasons for the difference in counting intervals were as follows. The
Memolog maximum sample size was 99,990 counts. Using a 5 second sample interval,
counts sometimes rose to 60 - 70,000 counts per 5 seconds. Increasing the sampling
interval would have taken the readings outside the range of the recorder. The
external gamma camera was capable of counting over 5 second intervals, but would
not plot or calculate regions of interest on more than 180 data points. This would
mean recording for 15 minutes only, before having to download the data onto tape,
and starting again. A compromise of 15 second sampling on the gamma camera was
decided upon as this would allow a 45 minute recording.
At time 0, with the subject lying under the gamma camera, 4milliCi 99TcmHIDA
was administered intravenously. Data acquisition was initiated for internal and
external gamma counting simultaneously, and gastric aspirations were started. Two or
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three consecutive 45 minute acquisitions were performed for each subject. The
progress of the labelled bile was also followed closely by visual screening.
Information from the Memolog was transferred to an Ericsson PC computer,
and a printout of the raw data obtained. For storage purposes, the internal probe
results were also downloaded from computer onto floppy disc. Gamma camera data
was transferred to a Nodecrest Micas III computer, and also stored separately on
magnetic tape
A program (CORRDLS) was written for the Nodecrest computer enabling the
gamma camera acquisitions (45mins each) to be merged, and then correlated with the
synchronised Memolog data. In each case the readings from the Memolog were
compared with the readings taken from a gamma camera region of interest over the
fundus of the stomach. It was possible to map the position of the stomach from its
relation to the liver during the 99TcmHIDA scan.
The results were plotted out graphically for visual correlation. Mathematical
correlation was performed using mean counts per minute for both sets of data.
Samples of gastric juice were aspirated at 5 - 10 minute intervals during tests 4
to 10. In order to compensate for radioactive decay during the test, 1ml aliquots of
all samples were measured simultaneously on a gamma counter (Nuclear Enterprise,
Edinburgh 8311), immediately after the test was concluded.
Results:
The main problem encountered with the above proforma was the difficulty in
obtaining aspirated gastric secretions from every subject. Satisfactory samples were
only achieved in 5 subjects. In the last two normal subjects, minimal or no aspirate
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was achieved during most of the acquisition tkme.
The results will be presented in chronological order, by subject, and then
tabulated. The first four cases should be regarded as pilot studies.
Subject 1 (PB. male, age 61) - Internal probe/pH test.
History of reflux symptoms, and endoscopically proven oesophagitis. No
previous surgery.
Two 45 minute gamma camera acquisitions performed for monitoring purposes,
with internal probe/pH electrode 5cm above the LOS. Internal monitoring was
continued for 100 minutes, until 99TcmHIDA reflux had occurred. The patient became
symptomatic with heartburn in the 87th minute, and this corresponded with a rise in
internal gamma counts, and a fall in oesophageal pH to around 3.9.
Subject 2 (ED, female, age 59) - Internal probe/pH test.
History of severe reflux symptoms, and endoscopically proven oesophagitis. No
previous surgery.
Four 45 minute gamma camera acquisitions performed for monitoring purposes.
The position of the probe and pH electrode were adjusted on four occasions to
measure activity above and below the LOS.
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Subject 3 (LH, male, age 74) - Internal probe/pH test
No history of acid reflux, but of waterbrash. The patient had undergone a
Billroth I gastrectomy for peptic ulcer disease in 1948.
Three 45 minute gamma camera acquisitions performed for monitoring purposes.
Probe and pH electrode initially placed in stomach, and then withdrawn into




Subject 4 (SC, female, age 66) - Internal probe/aspiration test.
History of heartburn and regurgitation, associated with severe oesophagitis, and
achlorhydria, suggesting bile reflux. No previous surgery.
Two 45 minute gamma camera acquisitions performed for monitoring purposes.
Probe assembly withdrawn into oesophagus following measurement of possible reflux
into stomach.
Mathematical correlation was not performed in the first four cases due to the
changes in probe position during the recording. For the remaining six cases the
probe was kept stationary in the fundus of the stomach, 5cm below the LOS, to
enable the computer correlations to be performed.
Subject 5 (RH, male, age 42) - Internal probe/aspiration test (Fig 33)
History of mild heartburn and anaemia. Gastroenterostomy for ?peptic ulcer
many years ago. Copious bile reflux into the stomach on endoscopy.
Two consecutive 45 minute acquisitions were performed. Graphs were obtained
of the gamma camera region of interest, but the data was compromised due to a
computer system failure, prior to measurement of mathematical correlation. There




Subject 6 (JR, male, age 77) - Internal probe/aspiration test (Fig 34)
History of heartburn and regurgitation, with oesophageal ulceration. No
previous surgery.
Two 45 minute gamma camera acquisitions were performed. The second was
correlated with internal probe readings. 99TcmHIDA reflux occurred, with good
visual and mathematical correlation between internal and external counts (r=+0.7937,
p < 0.01, n=45).
Subject 7 (FH, male, age 59) - Internal probe/aspiration test (Fig 35).
This patient had minimal reflux symptoms, but a Barrett's oesophagus on
endoscopy, and a highly abnormal pH test suggesting severe acid reflux. Two 45
minute gamma camera acquisitions both of which were correlated with internal probe
readings. Minimal 99TcmHIDA reflux occurred during the test, in keeping with his
symptoms, and internal/external gamma counts tailed off, with no rise after the
initial liver concentration of radioisotope. There was good visual and mathematical
correlation between the two sets of counts (r=+0.8922, p < 0.01, n=90).
Subject 8 (MC, male, age 25) - Internal probe/aspiration test (Fig 36).
Normal asymptomatic volunteer. Two 45 minute gamma camera acquisitions
both of which were correlated withinternal probe readings. Two 99TcmHIDA reflux
events occurred during monitoring, with good visual and mathematical correlation




Subject 9 (TE, male, age 25) - Internal probe/aspiration test (Fig 37).
Normal asymptomatic volunteer. Two 45 minute gamma camera acquisitions,
both of which were correlated with internal probe readings. No TcHIDA reflux
occurred on screening, although there was a late peak on the internal gamma probe
readings (55mins), which may represent some bile reflux. There was fair visual
correlation, and good mathematical correlation between the two sets of counts
(r=+0.7493, p > 0.01, n=90).
Subject 10 (RG, male, age 23) - Interna! probe/aspiration test (Fig 38).
Normal asymptomatic volunteer. Two 45 minute gamma camera acquisitions
both of which were correlated with internal probe readings. There was significant
99TcmHIDA reflux on screening, and good visual and mathematical correlation
between the two sets of counts (r=+0.5372, p > 0.01, n=90).
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Lapse and lag test
In order to examine the reliability of the correlation program, and the
synchronization of the above double sets of data, a lapse/lag test was performed on
two data sets (JR and FH). This test involved deliberately desynchronizing the data
set prior to correlation, by introducing a lag factor of one minute, then a lapse
factor of one minute. This produces two further correlation coefficients, both of
which should be less than that for the correctly aligned data (ie malaligned data
should not correlate as well as aligned data).
Lapse/lag correlation coefficients
Si JR
Lag - r=.6712 .5515
Sync - .8922 .7937
Lapse - .6798 .4824
In each case the synchronized data produced the highest correlation coefficient,




Summary of Results Comparing
Internal Probe Counts and Gamma Camera Counts in Ten Subjects
NAME AGE SEX CLINICAL
REFLUX
PROBE POSITION pH TEST ASPIRATION
PROBE/GAMMA CAMERA
CORRELATION
Peter BEESON 61 M BILE STOMACH/OESOPH YES NO
Elsie DIXON 59 F BILE STOMACH/OESOPH YES NO
Lawrence MEALY 74 M BILE STOMACH/OESOPH YES NO
Sylvia CLEEVE 66 F BILE STOMACH/OESOPH YES NO
Raymond HUGHES 42 M BILE STOMACH NO YES
James ROBINSON 77 M BILE STOMACH NO YES r - +0.7937 n = 45
Frank HOUGHTON 59 M ACID STOMACH NO YES r = +0.8922 n = 90
Mark CHURCHER 25 M NIL STOMACH NO YES r - + 0.5292 n = 77
Tim ETHERTON 25 M NIL STOMACH NO DRY r - +0.7493 n = 90
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Examination of all the internal/external gamma count curves reveals some
interesting similarities. During the first 30 to 40 minutes of each test, TcHIDA is
concentrated in the liver, excreted into bile, and then concentrated in the
gallbladder. Both the internal and external gamma detectors registered very high
counts immediately after intravenous injection of 99TcmHIDA, as the concentrated
bolus passed through the circulation. This initial peak rapidly declined due to
dilution within the circulation, and rapid uptake of "T^HIDA by the liver. A
smaller, shallower peak then appeared, as the radioisotope became concentrated in
the liver substance, then this too declined as the 99TcmHIDA was excreted in bile,
and stored in the gallbladder.
Ejection of "Tc^HIDA labelled bile into the duodenum had little effect on the
counts in the fundus of the stomach, but on screening, as soon as bile refluxed into
the stomach, the fundal counts started to rise. This is an inherent problem with the
internal probe - that it will not only measure counts when immersed in bile, but also
bile lying in a pool close by, for example, in the antrum of the stomach. The large
peaks in counts seen thereafter, were thought to be due to radiolabeled antral fluid
washing back towards the fundus of the stomach, and bathing the probe in bile.
Visual screening confirmed these events during testing.
The curve shape varied in those patients in whom no bile reflux occurred. In
these cases, after the initial rise in counts due to liver concentration of the TcHIDA,
there was a steady decline in counts, with no further rise, as no bile entered the
stomach, but drained distally into the small bowel.
The above observations have been further reinforced by mathematical
correlation between the internal probe counts and the gamma camera counts. These
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Figure are all highly positive with a range of +0.5292 to +0.8922, and a mean correlation









Asoiration curves - visual correlation only
This proved a less useful method of validation, as only small numbers of
samples (5 - 10) could be taken during testing. In two subjects, aspirations were
"dry", possibly due to the aspiration tubing impinging on the gastric mucosa.
In the three of the five cases where aspiration of bile from the region adjacent
to the gamma probe was successful, there was good visual correlation between high
probe counts, and high counts in the gastric aspirates, suggesting that the internal
probe was measuring refluxing bile (Figure 39). However in two cases there was
poor correlation, which may have been due to the aspiration tube slipping further
down into the stomach (Figure 40).
Mathematical correlations were not performed with these results
Possible artefacts
Enterohepatic circulation artefact can be ruled out as this does not occur when
using 99TcmHIDA. Other forms of artefact have also to be considered. These might




Duodenogastric bile reflux - gamma counts from
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In summary, this thesis has reviewed the literature, ancient and modern, on the
oesophagus, and its investigation. The current literature on oesophagitis has been
evaluated, and further ways of investigating the condition have been developed and
assessed.
From the historical and modern concepts review, it is clear that oesophagitis
was poorly understood until Winkelstein's classification of the condition in 1935.
Since then, the idea of oesophageal reflux as an abnormal phenomenon has been
developed, and enlarged upon in a multitude of studies. Despite this, oesophagitis is
still an incompletely understood "dis-ease", and many questions regarding aetiology
are yet to be answered. In the late 1980s, we are still not clear as to why some
patients present with severe symptoms, and minimal reflux disease, and conversely,
why some patients present late, with minimal symptoms, and severe disease. The
mechanism of oesophageal pain, and its relationship to pain of cardiac origin is still
being explored, and may yet reveal unexpected relationships between these two
closely apposed structures.
In particular, the question of mucosal acid damage versus bile salt damage has
been discussed, and the present controversies regarding this have been highlighted.
There is no question that acid is an important factor in the aetiology of oesophagitis,
but bile salts and enzymes also have a part to play which is as yet undetermined, due
to lack of accurate measurement techniques.
Oesophageal function can be quantified in a number of different ways, and the
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developments leading to present day techniques of oesophageal measurement have
been outlined. Tests fall into two categories. Firstly, those measuring structure, such
as endoscopy and X-Ray investigations. Secondly, there are the tests measuring
function. These include manometry, oesophageal transit studies, and pH testing.
Patterns of normal and abnormal oesophageal function are now well documented, but
measurements are far from standardized, making comparisons between groups of
subjects from different laboratories difficult.
In chapter 3, the five year endoscopic experience of reflux disease for one
group of gastroentgrologists, was quantified, showing that it is a widespread
condition, affecting all adult age groups, with a predilection for the elderly. It is
likely that there is a large undiagnosed pool of asymptomatic disease in the
community some of which may present late with symptoms of stricture or
oesophageal ulceration.
The "Gold Standard" test for gastro-oesophageal reflux today - 24 hour pH
testing - has been discussed, and critically assessed in chapter 4. pH testing reveals a
great deal about the patterns of acid reflux into the normal and abnormal
oesophagus, but from the studies on normal volunteers it is clear that there is a large
overlapbetween these, and the selected patient population. Some patients with severe
reflux symptoms, or proven oesophagitis had normal pH tests, while others with no
symptoms had severely deranged pH tests.
By examining the area under the curve of the pH 4 line on ph testing it was
hoped to create a better delineation between the normal and abnormal tests. This
proved not to be the case, with the AUC being no better at separating the normal
from the abnormal than the cumulative acid index. It therefore seemed that the
quantity, or concentration of acid present in the oesophagus was no more important
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than the time that the acid was lying in contact with oesophageal mucosa, when
attempting to predict whether a subject would fall into a normal or abnormal group.
This was surprising, as one might expect reflux at a lower pH to be more damaging
to mucosa than reflux at a higher pH.
The final conclusion from the chapter on pH monitoring was that, although it
may be the best available test for oesophageal reflux at the present time, it is far
from perfect. It was felt likely that other factors, unrelated to pH, may also be
playing a part in reflux disease, and that it was these unknown factors which were
decreasing the sensitivity of the pH test.
The constituents of oesophageal refluxate include not only acid, but also food,
drink (including alcohol), saliva, and varying amounts of duodenal secretions. These
have not been widely studied, and with the exception of bile salts, their combined
effects on oesophageal mucosa are unknown. One of the reasons for the lack of
quantitation of the constituents of reflux is that there is no completely satisfactory
technique for measuring it in its entirety. Various aspiration techniques have been
attempted, some in combination with pH monitoring, but none have been fully
satisfactory. Continuous aspiration of lower oesophageal contents is open to criticism,
as this will also measure swallowed saliva, and oesophageal secretions. In chapter 5,
the technique of endoscopic aspiration of oesophageal contents was utilized. This
again has its drawbacks, in that "spot" sampling only is performed. Also the presence
of the endoscope itself in the oesophagus introduces a further abnormal variable,
predisposing to reflux. Care was taken to avoid sampling from cases where retching
occurred during intubation, and this method is thought to be no less valid than other
aspiration techniques.
Measurements were performed on a number of samples of oesophageal
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refluxate, looking at other factors likely to cause damage to oesophageal mucosa,
namely bile salts, and the proteolytic enzymes, trypsin and pepsin. These were
compared with the pH of the refluxate. The results were revealing, in that significant
quantities of all three substances were found to be present in aspirated samples of
refluxate. More interestingly still, they were not just present and active in narrow
pH bands, but across a whole range from pH 1.5 to 7.5. Bile concentrations and
tryptic activity correlated with increasing pH.
These results raised the interesting concept of "non-acid" reflux as a cause of
oesophagitis. The idea of "alkaline" reflux leading to inflammation of the oesophagus
has been put forward many times over the years as described in chapter 2, but none
of the specimens tested were in the true alkaline range above pH 7.5. It therefore
seems possible that damage may occur in the oesophagus when refluxing fluid is in
the mid range of pH from 4 to 7. This would explain the poor discrimination
between normal and abnormal subjects using pH testing, programmed only to
measure changes below a set pH level (pH 4 in most cases). The results may also help
to explain the poor correlation between symptoms and signs of reflux, and pH test
results. It may be that measuring the time spent in different pH bands (pH 3-4, 4-5,
5-6 etc.) would improve the sensitivity of pH testing. DeMeester in the USA
(personal communication) is at present studying this concept, and his results are
awaited with interest.
Having demonstrated that oesophageal reflux in the mid pH range is occurring,
and may be causing inflammation, it is necessary to postulate a mechanism of
damage. As has already been mentioned, pH electrodes can only measure hydrogen
ion concentration in the oesophageal lumen, and tell us little about what is happening
at the cellular surface. The oesophageal mucosa is protected by a thin layer of
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mucus, and damage to this by enzymic action or bile salts may lead to greater
penetration of hydrogen ions to the cell surface, and an increased mucosal
cell/hydrogen ion contact time. Breakdown of the mucus protection layer would also
allow an increased bile salt, and proteolytic enzyme contact time with the mucosal
cell. At present this is a difficult concept to test, but if the aetiology of oesophagitis
is to be fully understood, further methods have to be found to examine the
pathological processes at a cellular level.
Some of the theories of biochemical and cellular damage were discussed in
Chapter 2, but these were mainly studies involving in vitro models. In order to
decide finally the relative importance of acid and bile in oesophageal reflux, a
method of studying in vivo damage in the human oesophagus is needed. One possible
way of achieving this would be to monitor electrolyte flux across the oesophageal
mucosal membrane, by measuring transmucosal potential difference changes. A
damaged mucous membrane becomes "leaky" to sodium, potassium and hydrogen ions
and reduces the transmucosal potential difference. It has to be recognised that
damage may occur to oesophageal mucosa which does not involve changes in
electrical potentials across mucosal surfaces, but this is a method which has been
used in animals with some success, and also in studies of the human stomach.
An alternative to continuing the study of reflux exclusively by pH testing,
which, after all can only measure hydrogen ion concentration, was to measure
concentration of other damaging factors in reflux. In this thesis, bile was chosen for
further study. The advantage of measuring acid reflux was that pH testing
equipment, suitably miniaturized and computerized was readily available. No such
equipment was available for bile testing.
Some limited studies of a "bile probe" have been performed at Guy's Hospital
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(Armstrong 1987) using an enzyme (3-alpha hydroxysteroid dehydrogenase) based
system. The aim of Armstrong's study was to produce a system for continuous
ambulatory monitoring of bile reflux. The probe built proved capable of measuring
bile acid concentrations down to 100microMol/l. There were problems with the
system however. Firstly, the probe was too large to be passed into the stomach.
Secondly, the probe would only measure bile acids within a fixed, narrow pH range
around 6. Outside this pH band the measurements became inaccurate due to enzyme
degradation, especially in acid environments. Thirdly, the enzyme tended to degrade
with time, although it was pointed out that this could be corrected for. Bearing in
mind the acidic nature of the stomach, the system was not therefore suitable for
gastric or oesophageal monitoring purposes, and it seemed unlikely to lead to an
effective clinical system. In chapter 6, an alternative method of bile monitoring was
investigated.
The radiolabelling of human bile has been possible for several years, and has
been used to investigate gallbladder disease (99TcmHIDA) and bile malabsorption
(75SeHCAT). By combining bile labelling techniques with a portable external gamma
monitoring system, it was felt that an alternative method of detecting bile reflux
could be developed. In practice the system, based on 75SeHCAT and the Memolog
600 external gamma detector, proved insensitive as a measure of bile reflux. The
reasons for this were insensitivity and lack of directionality of the gamma detector,
associated with high background counts from the liver and small bowel. It would
have been possible to increase the dose of radiolabel given, to counteract the
insensitivity of the detector, but this would have led to increasing problems with
background radiation "noise" within the system. Conversely, reducing the dose of
75SeHCAT given would reduce the background problems, but at the same time
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decrease the reflux detection rate still further. This "Catch 22" situation led to the
abandonment of the technique as a method of reflux detection.
The external probe studies did have positive aspects. In examining the reasons
for the high background radiation levels, it was realized that there were large
fluctuations in gamma counts over the liver and small bowel,and that these were due
to the enterohepatic circulation of radiolabeled bile. Ambulatory studies of
enterohepatic circulation patterns in man have not previously been recorded, and
although not directly relevant to the thesis it was felt that this was a useful finding,
and worthy of further study.
The modification of the external gamma monitoring concept to that of internal
gamma monitoring was not difficult. Bathing a detector in refluxing oesophageal
fluid seemed the ideal way to overcome the problems encountered with the external
system, which were mainly distance related. The practical application of this
modification proved more problematic, although eventually also more rewarding.
Apart from a single mention in the literature (Barber 1980) internal gamma detectors
for human use were unheard of, and unobtainable commercially. The first part of
chapter 7 outlines the successful development of a prototype internal gamma probe,
with its associated monitoring equipment. The probe itself was built with specialized
help from Radiation Monitoring Devices Inc. in the USA. The design specifications
were achieved, but initially portability proved a problem, with a mains preamplifier
limiting the mobility of the patients. A battery pack and holster were acquired late
on in the project, which made the equipment truly ambulatory.
Following the developmental program, in vitro studies showed the internal
probe to be highly sensitive to gamma photons, despite the tiny Cadmium Telluride
crystal it contained. The electronic problems associated with having a CdTe crystal at
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some distance from its preamplifier were overcome by a sophisticated
preamplification system. In practice, with the prototype used, this limited the cable
length to around 60cms, enabling the probe to be passed only as far as the fundus of
the stomach.
Having proved that the internal probe was capable of measuring the small
amounts of radiolabeled bile expected in oesophageal reflux, it was tested in human
volunteers (initially the author). Its performance was validated by comparing and
correlating internal probe counts with counts obtained from a gamma camera
focussed on the area occupied by the probe. For validation purposes, the ideal testing
site of lower oesophagus proved impractical, due to the unpredictability of reflux
events occurring during the limited monitoring time. The site chosen for validation
studies was therefore the gastric fundus, where duodenogastric reflux could reliably
be expected to occur in most subjects within the two hour period of testing.
In the limited number of cases studied, results were encouraging, and suggested
that the internal probe was indeed measuring bile reflux into the fundus of the
stomach, while avoiding to a large extent the problems of background radiation
encountered using the external probe. Bile aspiration studies were less conclusive, but
it was felt that the equivocal results obtained from some subjects were secondary to
developmental problems with the aspiration technique itself, rather than any intrinsic
defect in the gamma monitoring system.
The technique developed is not perfect, but at present is the only known method
for measuring bile reflux in ambulatory patients.
It is accepted that the number of patients tested is small, and that before the
system is developed further for clinical studies of bile reflux, a larger number of
validation studies needs to be performed, preferably with a refined technique for
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separate bile aspiration studies in parallel with gamma camera scanning.
The monitoring system as it stands is only a qualitative measure of bile reflux,
in effect measuring "ebb and flow" of radiolabeled bile into the stomach or
oesophagus. By comparing bile salt concentrations from aspirated refluxate samples
with gamma counts it may be possible to make it semi-quantitative, with high gamma
counts indicating high concentrations of bile salts, and low counts indicating low bile
salt concentrations.
The relationship between acid reflux and bile/trypsin reflux is complex. Bile
salts have been shown to reflux throughout the pH range, but a comprehensive
comparison of the patterns of bile reflux with those of acid reflux will only be
possible with further development of the techniques described. It may be that in a
subject, oesophageal reflux may be predominantly acid at one time of the day, and
mainly bile/trypsin at another time of the day. This would be shown by combined pH
and bile monitoring - a technique which would be quite practicable with few
modifications to the equipment used.
One of the main drawbacks of the internal gamma monitoring technique is that
the recording time is limited by the radioactive half life of 99TcmHIDA, and also the
fact that this radiolabel does not participate in the enterohepatic circulation. This
limits studies to two or three hours duration. The isotopic and physiological
characteristics of 75SeHCAT make monitoring possible over considerably longer
periods, but because it can only be given in such small quantities, the internal probe
is not sensitive enough to measure it. There are several possible ways around this
problem. Firstly, 99TcmHIDA could be given as an intermittent bolus, or a continuous
infusion over a longer period of time - for example 2mCi intravenous boluses at
three hour intervals for a total of twelve hours. One would have to allow for the
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artefact produced by the intermittent liver uptake and excretion of the isotope if this
method was used.
The ideal radiopharmaceutical would both take part in the enterohepatic
circulation, and be given in large enough quantities to be detected by the CdTe
crystal. One cannot rely on developments in radiopharmaceutical technology to
produce such a compound, although this is not outwith the realms of possibility.
From a more practical point of view, there are a number of ways in which the
gamma probe itself may be improved, possibly increasing its sensitivity enough to
measure 75SeHCAT, and certainly increasing its signal to noise ratio.
On completion of the research described in this thesis, a visit was arranged to
the facility of Radiation Monitoring Devices in Massachusetts, USA, to discuss
modifications which could be incorporated into a Mark II probe. A large number of
possibilities were discussed including the use of twin probes, in series, for the
measurement of bile flow rates. It is anticipated that the following modifications will
be made as a second stage in this ongoing project. Firstly, the initial fears about
electromagnetic induction creating excessive noise in the cable assembly proved
unfounded. Tests in the RMD laboratory showed that the cable length could
effectively be extended to 2 metres without undue interference occurring. This was
largely due to the high specification and characteristics of the preamplifier which
needed no further alterations itself. Although increasing cable length does not
increase the sensitivity of the probe, it does extend the uses to which it can be put,
for example, passing the probe on into the antrum of the stomach, and even the
duodenum and small bowel. Also the preamplifier could be placed at a distance from
the face, for example on a waistbelt.
The size of the probe could be reduced further. In a few patients it proved
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difficult to either pass the probe, or more often, remove it, due to impingement on
the turbinate processes. A reduction of 1mm in the diameter of the probe was
possible, and would overcome this problem.
Increasing the sensitivity of the probe proved possible by two methods. A
slightly larger CdTe crystal could be used (2mm wide by 4mm long), to increase
sensitivity to gamma irradiation selectively from sources lateral to the probe (ideal
for a probe immersed in radiolabeled fluid). Secondly, although collimation was still
not practical in such a small device, an element of shielding could be introduced.
Gamma irradiation from the liver and duodenum undoubtedly produced some
artefact in the recordings described in Chapter 7. By incorporating a tungsten, or
lead tip onto the probe, measurements from radiation "straight ahead" of the probe
would be reduced. These combined measures of a larger crystal, and shielded tip
would be expected to increase overall sensitivity to radiolabeled bile reflux.
One further possibility proved viable, and this was the incorporation of the
RMD preamplifier into the CdTe module attached to the Memolog recorder. Having
the electronics in one compact package would make the equipment as easy to carry
as pH monitoring equipment.
In conclusion, this thesis highlights the wide range of pH of oesophageal reflux,
as shown by 24 hour pH, and aspiration studies, and has developed the concept of
non-acid reflux as a cause of oesophagitis. A means of measuring bile salt reflux has
been devised, using a new gamma monitoring technique. With further development, it
is expected that this technique will clarify the position of bile reflux in particular in
the overall picture of oesophageal reflux.
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The concept and availability of a truly internal gamma monitoring device also
raises the exciting possibility of internal measurement of other radiolabeled fluids,
including blood constituents, and also solid organs and tumours.
In 1784 William Buchan noted in his "Treatise on the Prevention and cure of
Disease" that bile was one of the culprits causing heartburn, and suggested "a dose or
two of rhubarb and an infusion of Peruvian bark in wine" as a cure. He had no
means of corroborating his statements, or measuring the results of his treatment, but
now, two hundred years on, although the cause of heartburn and the aetiology of the
disease is still unclear, we are one step nearer to the answers.
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Appendix 1 - QUESTIONNAIRE
1.) HEARTBURN
None - 0 - No heartburn
Minimal - 1 - Occasional episodes
Moderate - 2 - Reason for medical visit
Severe - 3 - Interferance with daily activities
2.) REGURGITATION
None - 0 - No regurgitation
Minimal - 1 - Occasional episodes
Moderate - 2 - Predictable on position/straining
Severe - 3 - Episodes of pulmonary aspiration
3.) DYSPHAGIA
None - 0 - No dysphagia
Minimal - 1 - Occasional episodes
Moderate - 2 - Require liquids to clear
Severe - 3 - Episode of meat impaction
requiring medical treatment
NOTE: Value for heartburn + regurgitation + dysphagia = Total symptomatic score.
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Appendix 2 - Dietary exclusions - foods with a pH below 5.
PLEASE EXCLUDE THE FOLLOWING ACIDIC FOODS
FROM YOUR DIET
DRINKS: Orange juice/squash, grapefruit juice, lemon barley water, Ribena and
Lucozade. Also black tea or coffee.
SOUPS: Oxtail and Tomato.
DESSERTS: Tinned apricots, pineapples, pears and peaches. Fruit salad, fruit jellies,
trifles, stewed apple, rhubarb tart. Fresh oranges, apples and tangerines. Blackcurrant





Appendix 3 - PATIENT LOG
PROFORMA NUMBER: FILENAME: b:
PARAMETERS: pH Ext probe Int probe
NAME: UNIT NO. DATE OF BIRTH:
ADDRESS:
DATE OF TEST: TIME STARTED: TIME STOPPED:
MANOMETRIC LOS: LOS PRESSURE: PH LOS:
POST STUDY PH CALIBRATION: 1.68/ 6.97/
PLEASE RECORD IN THIS LOG ANY EVENTS OCCURRING DURING
MONITORING. THIS SHOULD INCLUDE:
TIMES OF DRINKS AND MEALS
NOTE ALL TIMES WHEN LYING DOWN (eg bedtime/getting up in
morning)
EPISODES OF HEARTBURN, INDIGESTION OR PAIN
AT THE SAME TIME DO NOT FORGET TO PRESS THE "EVENT" BUTTON ON
YOUR MONITOR.
INSTRUCTIONS ON DIET ARE OVERLEAF
DO NOT SMOKE DURING MONITORING.
AVOID USING ANTACIDS, BUT IF ABSOLUTELY NECESSARY, PLEASE
RECORD THE TIME AND AMOUNT TAKEN
IF THERE ARE ANY PROBLEMS, PLEASE PHONE:
Dept. of Gastroenterology. Gosport 584255 ext 2530




PART 1 Statistical analysis of pH data (Chapter 4)
The statistical techniques employed in this thesis for analysing multivariate data
are described in standard texts on multivariate analysis (Anderson, Mardia et al,
Morrison, Rao).
Sets of observations are available for two groups of patients - one group was
considered to have oesophageal reflux disease, and the other group was considered
"normal". The data for the two groups (1=1,2) can be summarised in terms of sample
means and covariance matrices. The mean vector Xj denotes xn, x[2 xJk, the set
of means corresponding to the k variables being considered.
We have asked the question; are the mean vectors for the two groups different?
If differences do occur, is it possible to allocate an individual (on the basis of his
experimental data)to one of the two groups?
The first question can be answered by evaluating the 2-sample Hotelling T2
statistic provided the sample covariance matrices Sr S2 are equal and the distribution
of observations are multinormal. Equality of covariances can be assessed by Box's M
test, and Mardia has proposed a test of multinormality based on the multivariate
measures of skewness and kurtosis.
The second question involves methods of discriminant analysis. When the forms
of the distributions of the two groups are known (e.g. multinormal) but their
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parameters are unknown, the "sample maximum likelihood discriminant rule" can be
used. Assuming the two groups of data are samples from multinormal distributions
with different means (estimated by xr 12 ) and the same covariance matrix
(estimated by § ), the sample maximum likelihood discriminant rule allocates an
individual with data x to group 1 if and only if
( 2L, - x2 )'S"1 (x - 0.5( x1 + x2 )) > 0
The expression y = ( x1 - x2 )'§"1 x is referred to as the linear discriminant
function or discriminant score (when x is assigned values) and can be evaluated for
all individuals in the two groups. A plot of the sample cumulative distribution
function for the two groups can illustrate the amount of separation between the two
groups.
In considering the discrimination problem between two multinormal populations
with different means and common covariance matrices there may be some variables
that have no discriminatory power once other variables have been taken into account,





1.) Hotelling's T2 test.
• • • • P
This is the multivariate equivalent of the Student t test and will agree in value
when only one variate is being studied. An "F" variate with degrees of freedom 1 and
m is equivalent to a Mt" variate squared with m degrees of freedom.
Results have been presented in terms of the multivariate tests even when one
variate only is under study.
2.) Elimination of variables having no discriminatory power
The 2 sample Hotelling's T2 statistic can be expressed as:
nrng( x1 - x2 )'S"1 ( 2L1 - 2L2 )
n
for any number of variables. For p variables let the statistic be T (say).
(n1 and n2 are the two sample sizes, and n = n1 + n2 )
A test for considering if (p - k) variables can be discarded in the presence of k
other variables uses the statistic:
(n1 + n2 - p - 1) . (T2p - T2u) (with p > k)
(p - k) (n, + n2 - 2 + T2k)
Under the null hypothesis of no useful additional information from the (p - k)
extra variables, the statistic has the F k n1+n2-p-i distribution and is rejected for
large values of this statistic.
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The variables tested in this case were as follows:
1.) Cumulative acid index (CAI%)
2.) Erect CAI%
3.) Supine CAI%
4.) Area under the curve (AUC)
5.) Erect AUC
6.) Supine AUC
7.) Total number of reflux episodes






1.) Controls v. Patients (Variables: Reflux, Length, Pressure, CAI%)
Data analysis have been conducted on 41 "controls" and 73 "patients" (endoscopy
score 1,2, 3 or 4). Summaries of the multivariate tests underlying the analyses are
given in Table A. It has been necessary to apply a loge transformation to various
variates in order to reduce skewness. It is readily apparent that for combinations of
variates, the statistical assumptions are not fulfilled entirely. Broadly speaking, in the
presence of non-normality, the normal theory tests on means are influenced by
skewness, whereas the tests on covariances are influenced by kurtosis. Skewness
appears mostly with the "patient" data and inequality of covariances generally arises
2 • • •
as the number of variates increase. In these situations the Hotelling's T statistic is




For the combinations, or single variates shown in Table A, it can be concluded
that the groups of "controls" and "patients" can be considered as having significantly
different mean values, with some of the variates illustrating higher levels of
separation (or discrimination) between the two groups.
Of the four single variates reflux, length, pressure and CAI%, CAI% and length
are the best two discriminators. Of the combinations of the three variates reflux,
length, and CAI%, either (i) reflux and length, or (ki) reflux and CAI% can be
dropped with a single variate CAI%, or length, being the discriminatory variate.
Figures 11 and 12 illustrate the separation between the two groups presented in
terms of the cumulative distributions. Table C provides summary statistical measures
for the two groups of subjects.
2.) Controls v. Patients (Variables: Reflux, Length, CAI% and AUC)
The area under the curve (AUC) has been calculated for 28 "controls" and 31
"patients". The corresponding data for reflux, length, and CAI% have been co-
examined to indicate the best discriminators (if any) between the two groups of
subjects. Summaries of the multivariate tests are given in Table B.
Similar findings to that described above in (1.) are found relating to statistical
assumptions. From this limited set of data either CAI% or AUC can be considered as
the best discriminator. Other variates indicate significant differences in mean values
for the two groups, but not to the same degree as CAI% or AUC. Table D shows the
summary statistical measures for the two groups of subjects.
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Patients: Endoscopy score 1 versus endoscopy score 2.3 or 4.
Using the same methodology as described previously, the two groups of patients
have been compared on the basis of endoscopy score. Endoscopy score of zero has
been excluded. Summary multivariate tests are shown in Table E.
For combination and single variates analysed there are no significant differences
in average values between the two endoscopy groups. The pressure variate suggests
there is a significant difference between average values, but in view of the skewness
and kurtosis for the second endoscopy group, the result should be left open for
question and further investigation in a larger study.
The sample sizes for the AUC variate are small and further investigation of
AUC in larger groups may be advisable before firm conclusions can be drawn in this
case about the difference between the two endoscopy groups. Table F provides
summary statistical measures for the variates studied.
CAI% erect/supine data
In view of the large proportion of zero values, particularly in the "controls",
and the moderate to severe skewness of observations, it was not practical to apply a
statistical test based on "normal" theory (i.e. a parametric test). Comparison between
these two interdependant sets of data was possible using a non-parametric test known
as the Kolmogorov-Smirnoff 2 sample test, which finds the maximum differential
between 2 sets of non-parametric data.
The difference between control and patient data was significant at the 1% level
for both Erect CAI%, and Supine CAI%. The maximum differential for the Erect




PART 2 Bile, trypsin and pepsin analysis (Chapter 5)
Endoscopy score
Information for 47 patients on endoscopy score, pH, bile concentration and
tryptic activity has been analysed by the techniques already described, by generating
two groups of patients according to endoscopy score - Group A, with a score of 0 or
1, and Group B, with a score 2,3 or 4.
Table G summarises the statistical tests and summary measures. There is no
significant difference in the average values for the two endoscopy groups (based on
the multivariate test for the three variables pH, bile concentration and tryptic
activity. The two variables bile concentration and tryptic activity required a loge
transformation to fulfill the statistical assumptions of the tests. If there had been a
progressive increase or decrease in the three variables with endoscopy score, then the
above analysis using two endoscopy groups should have yielded significant
differences in average values.
Bile in post-eastrectomv/normal stomach/oesophagus
Bile concentrations (loge transformed) for the above three groups of patients
(sizes 8, 17, and 43) have been compared by the one way analysis of variance
method. Log transformation was again necessary to fulfill the normality assumption
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employed in the analysis of variance test. Average (log) values for the post¬
gastrectomy, normal stomach and oesophagus groups are 7.39, 5.31 and 5.29
respectively. These values are significantly different (p > 0.01) with the post¬
gastrectomy group having a significantly higher average value compared to the other
two groups. The normal stomach and oesophagus groups are not signifiantly
different. The post-gastrectomy group is relatively small and does not contain any
very low values, but does contain the two highest values of all three groups.
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Table C.
Summary Statistical Measures for 3 Variates








CONTROLS 3.19 1.58 0.28
PATIENTS 4.00 3.33 2.22
COVARIANCES
CONTROLS REFLUX (LOG) 1.20 0.91 1.55
LENGTH (LOG) 0.91 1.65 1.83
CAI% (LOG) 1.55 1.83 2.57
PATIENTS REFLUX (LOG) 1.11 0.16 0.61
LENGTH (LOG) 0.16 1.65 1.29




Summary Statistical Measures for 4 Variates










CONTROLS 3.14 1.42 0.10 -1.61
PATIENTS 4.37 2.99 2.03 0.34
COVARIANCES
CONTROLS REFLUX (LOGe) 1.59 1.09 1.93 1.81
LENGTH (LOGe) 1.09 1.63 1.88 1.81
CAI% (LOGe) 1.93 1.88 2.83 2.69
AUC (LOGe) 1.81 1.81 2.69 2.75
PATIENTS REFLUX (LOGe) 0.85 0.58 0.85 0.99
LENGTH (LOGe) 0.58 0.89 0.83 0.93
CAI% (LOGe) 0.85 0.83 1.10 1.21
AUC (LOGe) 0.99 0.93 1.21 1.47
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Summary Statistical Measures for Variates
in the Comparison of Patients with
Endoscopy Score 1 Versus
Endoscopy Score 2, 3 and 4
MEANS VARIANCES
ENDO 1 ENDO 2+ ENDO 1 ENDO 2+
REFLUX (LOG) 4.01 4.00 0.94 1.30
LENGTH (LOG) 3.16 3.49 2.02 1.41
PRESSURE 22.5 14.9 112.6 148.5
CAI% (LOG) 2.12 2.34 1.56 1.27
AUC (LOG) 0.08 0.56 1.25 1.49
NOTE: Sample sizes of the 2 groups are 30 and 41 for all




Bile Study: Statistical Tests and Measures
for pH, Bile Con (Log), Trypsin (Log)
ENDOSCOPY GROUP
SCORE 0+1 SCORE 2+3+4




SKEWNESS X2(d,f) 4.08 (10) 3.55 (10)
KURTOSIS N(0,1) -1.59 -1.79
EQUALITY OF COVARIANCES BOX'S TEST X2 = 7.07 d,f = 6
HOTELLING'S T2 1.11






ENDOSCOPY 0+1 4.24 5.60 -1.69
ENDOSCOPY 2+3+4 4.77 5.61 -1.15
COVARIANCES
ENDOSCOPY 0+1 PH 4.29 1.63 3.40
BILE CON (LOG) 1.63 2.53 3.14
TRYPSIN (LOG) 3.40 3.14 8.95
ENDOSCOPY 2+3+4 PH 4.56 2.60 6.02
BILE CON (LOG) 2.60 3.56 3.80
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Appendix 5 - Circuit diagram of internal probe preamplifier
PCT 2C PREAMPLIFIER-
REV. C PARTS LIST
MAY 14, 19B7
PART DESCRIPTION VALUE RATING
R 1 CARBON COMP. 10 M 1/4 w
R CARBON COMP. 200 M 1/4 w
R 3 CARBON COMP. 750 1/4 w
R 4 CARBON CDMP. 100 K 1/4 W
R 5 CARBON COMP. 470 1/4 UJ
R 6 CARBON COMP. 20OK 1/4 w
R 7 CARBON COMP. 10 K 1/4 w
R 8 CARBON COMP. 10 K 1/4 w
R 9 SINGLE TURN POT 20 K 1/4 w
R 10 CARBON COMP. 120 1/4 w
R 11 CARBON COMP. 120 1/4 w
C 1 MONOLITHIC 0. 1 uF 100 V
c 2 MONOLITHIC 0.082 LiF 100 V
c 3 MONOLITHIC 0.012 uF 100 V
c 4 MONOLITHIC 0.01 uF 500 V
c 5 CERAMIC NPO 470 pF 300 V
c 6 CERAMIC NPO 6 pF 100 V
c 7 MONOLITHIC 10 pF 100 V
c B TANTALUM 47 uF 25 V
c 9 TANTALUM 47 uF °5 V
c 10 MONOLITHIC 100 pF 100 V
c 11 MONOLITHIC 27 pF 1 I<v
J 1 CONNECTOR 6 PIN
J 2 CONNECTOR BNC FEMALE PANEL MOUNT
tc 1 HYBRID PREAMP CS-507-1
:c 2 OP AMP HA—2625-5
[C 3 OP AMP HA-2625-■5
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